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Background: Hepatitis B infection has been emerging without warning and quickly spread in our 
globally connected world, considered a noticeable health issue. Vietnam is contemplated as a highly 
endemic of chronic hepatitis B, which contributes factor to the most common cause of cancer death. 
Prevention and control HBV in Vietnam mostly depending on the immunization program and 
regular HBsAg screening. This study aimed to evaluate the efficiency of Hepatitis B vaccination 
implementation period of EPI in Vietnam from 1981-2019. Method: a cross-sectional study, 
population-based was performed from 4 provinces in Central Region, Vietnam (Khanh Hoa, Binh 
Dinh, Quang Ngai, Ninh Thuan). Data was collected from 2075 participants from 1-39 years old in 
June to July 2019 by statra classification method and random selection. Participants were 
interviewed about geography demographic, environmental and attitude factors, and testing HBsAg 
(+) through a quick test, which affected their HBV infection status. Results: Our study found out 
the association between the prevalence of HBsAg(+) with age- groups (<18 years old (OR: 0.228, 
95% CI: 0.145-0.359, p<0.001); attendant for delivery, including: medical staff (OR: 0.489, 95% 
CI: 0.330-0.725, p<0.001); traditional birth attendant (OR: 2.015, 95% CI: 1.321-3.076, p=0.001); 
family member & relatives (OR: 1.891, 95% CI: 1.087-3.289, p<0.05); reason to choose delivery 
place : Individual selection (OR: 2.264, 95% CI: 1.045-4.904, p<0.05); family member have 
Hepatitis B: No (OR: 3.861, 95%CI: 2.079- 7.171, p<0.001;);  Unknown(OR: 0.518, 95% CI: 0.30- 
0.895, p<0.05); vaccination history: Unknown (OR: 4.739, 95% CI: 1.808-12.422, p<0.05) and 
availability of immunization cards: No (OR: 2.988, 95%CI: 1.300-6.867, p<0.05;).Conclusion: 
Hepatitis B infection was still a significant cause among children younger and adults from 1-39 
years old in Vietnam. In the context of low vaccine proportion or uncertain their historical 
vaccination, and the HBsAg (+) prevalence is mostly in the adults; getting a full schedule of 
Hepatitis B vaccine and checking the status are very important, in particular, population who have 
not had a chance to approach vaccination due to their external condition during their childhood and 
their behavior compared to children. There is a need to consider the community communication to 
vaccinate frequently in the Expanded Program on Immunization within this dramatic situation.  






Hepatitis B infection has been emerging without warning and quickly spread in our 
globally connected world, considered a noticeable health issue. There are acute and chronic 
hepatitis B, modified from a wide range of illnesses from asymptomatic to symptomatic, 
progressive disease[1]. Worldwide, there was an estimated over two billion people infected 
with hepatitis B and 360 million chronically infected persons[2, 3]. The burden of chronic 
HBV stands high disproportion in low- and middle-income countries (LMICs), particularly 
in Asia and Africa[4]. At the present, there is no specific treatment hepatitis B then all of 
the expenses from treatment were a dramatically vast health finance problem toward the 
national economy and patients out of pocket. In China, the huge direct cost spending on 
HBV- related diseases accounts for 30,72% to 297,85% out of annual family income for 
acute Hepatitis B and primary liver cancer respectively[5]. It also occurs in developed 
countries like South Korea, during the 2008-2011 period, the amount of economic cost for 
hepatitis B rose significantly, from US $501.4 million to US $607.8 million. The 
roundabout cost approximated around 53.4% out of this total[6]. Besides, the chance to 
approaching health care system is a considered issue for developing countries, especially 
in the mountainous and rural areas where residents have a few occasion to enter because of 
environmental factors.  
Hepatitis B can be prevented by vaccination and is therefore incorporated in routine 
vaccination or mass vaccination programs in many countries. With support from Expanded 
Program on Immunization (EPI), established by the World Health Organization (WHO) in 
1974 to support countries uptake of vaccines against Hepatitis B has been increased.   
Many studies have found the relevance between HBV and age. The young have a 
higher prevalence of illness than adults, to be specific the percentage of those infected 
perinatally, in early childhood, and after age five years are 90%, 30%, 60% respectively[3]. 




material effect on the proportion of HBV related death prevented [7]. Moreover, routine 
hepatitis B vaccination of infants plays a key role in the process of reducing the morbidity 
at the young age without birth dose, which would prevent up to 75% of death globally. 
With 100% complete vaccine series coverage and 100% of infants receiving a birth dose 
of vaccine, it would be theoretically possible to prevent 95% of all HBV- related deaths[7].  
Vietnam is contemplated as a highly endemic of chronic hepatitis B, which 
contributes factor to the most common cause of cancer death. There was an estimation in 
chronic infection prevalence of HBV among adults from 8-20% [8-11]. It also referred to 
this figure of infant, children (4-5 years), adolescents (14-15 years), and adults (25-39 
years) were 12%, 18%, 29% and 19%, respectively in a survey of two districts in Thanh 
Hoa Province in1998 [12].  
Prevention and control HBV in Vietnam mostly depending on the immunization 
program and regular HBsAg screening. At the moment, this duty is being in charge and 
funding by government and international organizations. Hepatitis B disease will put a load 
of burden on community health in Vietnam in upcoming if appropriate intervention is not 
used promptly and properly. Establishment of a national strategy for HBV prevention and 
control is crucial to develop and implement effective interventions[13]. Despite the 
effectiveness of HBV vaccine introduced around 3 decades ago, Vietnam is classified as a 
high burden country regarding HBV which is one of the most popular and dangerous 
etiology of liver disease.  
 The number of provinces implementing hepatitis B vaccination has increased 
over the years from 29 provinces in 1998 to 42 provinces in 2000. Since 2003, with the 
support of the GAVI organization, the Hepatitis B vaccine has been deployed to children 
under 1 year old in routine vaccination with 100% of districts nationwide covered. From 
2006 up to now, the rate of vaccination for hepatitis B with 3 doses in children under 1 year 
old has always reached over 90%, except in 2007, which was low due to lack of 




of Hepatitis B vaccination in the 2000-2008 period", thereby determining the prevalence 
of HBsAg infection in Vietnamese children. The survey was conducted in 51 provinces / 
cities with over 7,000 children born between 2000 and 2008. The results showed that 
having HBV vaccination significantly reduced the proportion of children with HBsAg (p 
<0.05) compared to the group of children not receiving the injection. Besides, the 
vaccination with the basic dose (3 doses) significantly reduced the rate of children carrying 
HBsAg (p <0.05) compared with the group of children who had not received enough shots 
(1 or 2 shots). In particular, the survey results show a marked decrease in the prevalence of 
HBV virus among groups of children born in the period 2000-2008. The group of 5-year-
olds at the time of the survey (born 2006) had a hepatitis B virus infection rate of 1.89%, 
achieving the WHO target of reducing the rate of hepatitis B virus infection among 5-year-
old children. to below 2% in 2012 and work to reduce this rate to below 1% in the 
future.[14] 
 A significant achievement was established in Expanded Program on 
Immunization (EPI) in Vietnam, while the country experienced repeated disease outbreaks. 
Nguyen Van TT’s study showed the prevalence of current HBV infection - HBsAg(+) has 
found extent from 10% to 20% in the general population and 20% to 40% among injecting 
drug users and HIV positive patients[13]. The prevalence of chronic HBV infection is 8–
20% and 31–54% among the general and the urban high-risk populations, respectively [15]. 
Various projects and modeling studies predict around 8 million chronic HBV cases and 
approximately 58,600 HBV related liver carcinoma in Vietnam by 2025. It is also estimated 
the HBV-related death will be 40,000/year by 2025 [10, 16, 17]. 
Since the country introduced hepatitis B vaccination, modification of HBsAg 
prevalence has not been investigated by a population-based survey previously. Therefore, 
we investigated the influence of the expanded immunization program through this topic: 
“Associated factors with Hepatitis B virus infection after 39 years of Expanded 
Program on Immunization in Central Region, Vietnam.” in 2 age group under 18 years 




than those of ≥18 years old age group thanks to EPI “, due to the high probability of 
transmission from mother to children in their age of reproduction. Moreover, we also want 
to compare the efficiency of Hepatitis B vaccination to community after the melioration of 
EPI (1998-2000). The evaluation of HBsAg positive prevalence in children and adults 
among the representative population in four provinces (Khanh Hoa, Ninh Thuan, Binh 
Dinh, and Quang Ngai) in Central Region, Vietnam which may contribute to understanding 
disease epidemiology, valuable information to assess the effectiveness of preceding 
vaccination, formulating future immunization policy and use it for preventive measures in 
the future as well as finding the relation among prevalence of Hepatitis B immunization 



















2.1.  HEPATITIS B VIRUS OVERVIEW 
2.1.1. Hepatitis B Virus Concept 
There are five categories hepatitis (A, B, C, D,E) in which hepatitis B- formerly called 
serum hepatitis, is one of the most hazardous infectious 
diseases out of these. HBV is a small, double-shelled virus, 
belongs to the family of Hepadnaviridae and has been 
recognized as separate entities since the early 1940s and can 
be diagnosed with specific serologic tests. It may take place 
with AHB infection (coinfection) or HBV carrier 
(superinfection)[18]. According to Lok et al in Chronic 
Hepatitis B (2001), the HBV genome is frame as a relaxed 
circular, partially double-stranded DNA of approximately 3,200 base pairs. The open 
reading frames encoding the envelope (pre-S/S), core pre-core/core), polymerase, and X 
proteins are partially overlapped [19, 20] in which the large (L), middle (M), and small (S) 
surface glycoproteins are encoded by pre- S/S open reading frame.  
2.1.2. Hepatitis B Classification  
2.1.2.1. Acute hepatitis B 
AHB happens when a person is first infected with hepatitis B. Adults often 
experience clinical signs and symptoms more than infants or children where the prevalence 
of developing symptoms in infants, children from 1 to 5 years old and older children and 
adults are less than 5%, 5-15%, 33-50% respectively [21]. Especially, adults usually have 
an asymptomatic acute course, though this figure was just approximately 50% out of AHB 
patients. Most cases in healthy people who was infected, do not express any symptoms and 
exclude virus following natural recovery and active adaptive immunity of body. HBsAg 
and the production of anti-HBs will eliminate completely in several months later and create 
(Source:  Center for Diseases Control 
and Prevention ) 
 




immunity to future infection. In the contrast, if infected body can not get rid of the virus 
after six months turn out it will progress to CHB. There is only 1-2% caused of fulminant 
hepatitis with a numerous of injured liver cells and get change of fatal. It estimated around 
200-300 Americans death caused by fulminant disease each year (case-fatality rate 63% to 
93%)[18, 22].  
It is undifferentiated clinical course among types of acute viral hepatitis, including 
AHB. The incubation period ranges from 45 to 160 days (average, 120 days). Before the 
onset of jaundice 1 to 2 days, several initial nonspecific symptoms like malaise, anorexia, 
nausea, vomiting, right upper quadrant abdominal pain, fever, headache, myalgia, skin 
rashes, arthralgia and arthritis, and dark urine appear. It is called preicteric, or prodromal 
phase, which takes place around 3 to 10 days. Jaundice, light or gray stools, hepatic 
tenderness and hepatomegaly (splenomegaly is less common) represent for icteric phase, 
which is variable but usually lasts from l to 3 weeks. Malaise and fatigue may maintain 
during convalescence for weeks or months, while other symptoms disappear. Blood testing 
identifies clearly AHB infection through the positivity of HBsAg, anti-HBc, IgM anti- HBc 
and negativity of anti- HBs [18]. 
2.1.2.2. Chronic hepatitis B  
Chronic hepatitis B is chronic inflammatory disease of the liver caused by 
persistent infection with the existence of HBV for more than six months (after their first 
blood test result).  It is considered as a high risk cause of liver diseases. HBeAg-positive 
and HBeAg-negative are classified into two subgroups of chronic hepatitis B [18]. 
CHB patients may not recognize their disease due to frequently asymptomatic status, which 
enhances the high risk of infecting others and has been referred to as carriers. The 
proportion of chronic HBV- related diseases such as chronic hepatitis, cirrhosis, liver 
failure, and hepatocellular carcinoma is prevalent, in which 25% of deaths prematurely 
from cirrhosis or liver cancer. There is 25% of carriers acquire chronic active hepatitis, 
result in cirrhosis. Comparing to CHB infected persons, noncarriers experienced the low 




2.1.3. Transmission of Hepatitis B 
2.1.3.1. Reservoir 
Human is known for the only host for HBV, although other primates have been 
infected in laboratory conditions. Until now, there is no evidence about the existence of 
HBV in animals, insect hosts, or vectors [18].  
2.1.3.2. Transmission 
The proportion and patterns of transmission are different from parts of the world. 
The high prevalence chronic HBV infection which accounted for greater than 8% HBsAg 
positive in general population is 45%, while this figure for moderate prevalence areas (2% 
to 7% of the population is HBsAg positive) and a low prevalence (less than 2% of the 
population is HBsAg positive) are 43%, 12% respectively.  
The way of HBV’s transmission through perinatal, percutaneous, sexual exposure 
and close contact between persons by open cuts and sores with HBsAg positive body fluids 
from persons who have HBV infection (acute and chronic), especially among children in 
hyperendemic areas [18, 23-26]. 
 It is also classified into horizontal transmission and vertical transmission. Among 
individuals have high-risk sexual behavior such as unprotected anal and vaginal sex or 
persons who use contaminated injecting devices together experience the enhanced risk of 
HBV infection are called horizontal transmission. HBV infection is coinfected with 
hepatitis C (mostly through using injectable drugs) and hepatitis D (required the presence 
of HBV), at 10-15%, 5% respectively [27]. Vertical transmission occurs from mother to 
child (perinatal transmission) at birth or infancy period, which is very efficient. The 
prevalence of infants may acquired HBV infection from their mother who is positive for 
both HBsAg and HBeAg reaches 70-90% if they do not have postexposure prophylaxis. If 
the mother is positive only for HBsAg, the risk of perinatal transmission is about 10%. 




The level of HBV density is different, the highest concentration are in blood and 
serous fluids, while in other fluids like saliva, tears, urine, and semen are lower titers [28].  
There is no clear proof for HBV transmission from person to person via tears, sweat, urine, 
stool, or droplet nuclei. 
HBV can survive outside the body for prolonged periods. The transmissible 
capacity of HBV remains at least 7 days on environmental surfaces through open cut or 
sore, even without the visible blood [29, 30]. Injection-drug use plays an important mode 
of transmission, without overt needle puncture, break in the skin like fresh cutaneous 
scratches, abrasions, burns, or other lesions, may also be a convenient entry.  
Nosocomial exposures like transfusion of blood or blood products or hemodialysis, 
use of meters and lancets for glucose monitoring, insulin pens, and needle-stick or other 
“sharps” injuries sustained by hospital personnel have all resulted in HBV transmission. 
Few cases in which transmission from HBsAg-positive health care personnel to 
patients has been documented, particularly since implementation of standard universal 
infection control precautions [31]. In many countries, the proportion of HVB transmission 
among patients in dialysis centers is high due to failure to adhere to recommended infection 
control practices against transmission of HBV and other blood-borne pathogens in these 
settings. IG, heat-treated plasma protein fraction and albumin are viewed as protected. 
Before, outbreak have been followed to tattoo parlors, acupuncturists, and barbers. 
2.1.4. Laboratory feature and Diagnostic criteria 
Diagnosis is cooperation among clinical, laboratory, and epidemiologic 
discoveries.  Not only clinical symptoms can represent for HBV infection but also 
definitive diagnosis relies upon the results of serologic testing. There is a modification of 
presence of the serologic maker between acute and chronic HBV infection. HBsAg can be 
found in blood and body fluids for 1–2 months before and after the onset of symptom. 
HBsAg is the most usually utilized test for diagnosing acute HBV or detecting carriers 




sensitive assays are used. Whether acute or chronic HBV infection, there always has the 
appearance of HBsAg. Similarly to HBsAg, the presence of anti- HBc (core antibody) in 
all of HBV infection, appears shortly after HBsAg in AHB but it is not a serologic marker 
for acute infection. Anti-HBc reminds of an infected HBV indeterminate time in the past. 
There is no appearance of anti- HBc in person who receives HBV from hepatitis B vaccine.  
Figure 2. Interpretation of Hepatitis B Serologic Tests [18] 
Test Result Interpretation (*)Postvaccination testing, 
when it is recommended, 
should be performed 1-2 
months following dose #3. 
(a) 1. Maybe recovering 
from acute HBV infection. 
2. Maybe distantly 
immune and test is not 
sensitive enough to detect 
a very low level of anti-
HBs in serum. 
3. Maybe susceptible with 
a false positive anti-HBc. 
4. Maybe chronically 
infected and have an 
undetectable level of 


























































2.1.5. Treatment and Prevention - Role of vaccination 
2.1.5.1. Treatment  
Although there are plenty of efficient medicine can control and even stop the 
development of HBV from further damaging a liver, treatment is supportive. There is no 
specific treatment for AHB [32]. 
Interferon alpha (IFNa, or PEG-IFNa) and nucleoside or nucleotide analogs (lamivudine, 
adefovir, entecavir telbivudine, and tenofovir) are considered as two major groups of 
antiviral treatment, have been licensed for the treatment of chronic HBV infection in many 
countries. Depending on the physical conditions of CHB patients, all of decision to treat or 
choosing the appropriate therapy has made. The progress of considering, choosing the 
appropriate of therapy or treatment depends on individual status of chronic HBV infection. 
Patients with HBV DNA levels above 2000 IU/ml, serum alanine aminotransferase levels 
above the upper limit of normal, and severity of liver disease assessed by liver biopsy (or 
non-invasive markers once validated in HBV-infected patients) generally are considered 
for treatment showing moderate to severe active necroinflammation and/or at least 
moderate fibrosis using a standardized scoring system[18]. 
It is a costly payment for prolonged treatment to maintain suppression of viral 
replication in both developing and developed countries. However, medications have 
significant side effects that require careful monitoring. Combination of therapy are been 
considering in study, but it is likely to reduce the appearance of virus mutants resistant to 
treatment. Overall, there are promising new drugs in the future which can control and even 
cease the hepatitis B infection as well as further damage and complications.  
2.1.5.2. Prevention- Role of vaccine 
2.1.5.2.1. Vaccine 
Apart from another preventive methods such as reducing the horizontal 
transmission from person to person through blood and other potentially infective body 




tools (toothbrushes, razors,..) with household members in AHB or CHB infection or in the 
hospital setting, patients with HBV infection should be managed with standard precautions. 
Hepatitis B vaccine plays an important role in the worldwide prevention strategy.  
 Hepatitis B vaccine was launched in United State since 1981 which have had a large 
effectiveness on AHB disease although it is less optimal on CHB disease. However, there 
are so many impact on dramatic reducing complications such as HCC in Alaska Natives 
[18] and the successful influence of immune program on infants, children and adolescents 
about the prevalence of AHB and then CHB [33]. There are multiple formulations (Re- 
combivax HB and Comvax, Merck; Engerix-B, Pdiatrix, and Twinrix, GlaxoSmithKline) 
are now licensed in the United States, which products from yeast (Saccharomyces 
cerevisiae) and recombinant techniques to generate the hepatitis B surface antigen 
(HBsAg) protein [34]. 
A variety of strategies to reduce the prevalence of HBV universal, especially 
concentrate on the target population in 2011[18] such as prenatal testing of pregnant 
women for HBsAg to indicate a proper immunoprophylaxis for prevention of perinatal 
infection in infant and contacts, a routine vaccine for infants, adolescents, adults at high 
risk for infection. However, it still remains three major risk groups (heterosexuals with 
multiple partners or contact with infected persons, injection-drug users, and men who have 
sex with men) can not reach the impact of immunization program.  The most implicit 
reasons of these groups are lack of awareness about risk of HBV infection and its 
complications and consequence, lack of effective public or private sector programs, and 
vaccine cost. Accessing to these population is considered a problem [18]. 
HepB-BD considers as an important key factor in reducing the prevalence of HBV 
infection and the proportion of HCC. The first plasma-derived hepatitis B immunization 
was licensed in USA in 1981 which was replaces in 1986 and by recombinant HBV vaccine 
in 1989[35]. The amount of antiHBs antibodied in greater than 95% in infants who 




booster doses[36]. According to WHO’s recommendation that HepB-BD should 
vaccinated as soon as possible after birth, better within 24 hours, to prevent perinatal HBV 
transmission. The birth dose still remains its effectiveness if given after 24 hours, although 
comparing to this monovalent HBV within this time, it has less significant impact[37]. Two 
subsequent booster doses such as monovalent hepatitis B vaccines or HBV containing 
combination childhood vaccines should followed the HepB-BD. Mainly, birth dose for 
infants as well as Hepatitis B immunization for children are currently recommended in 
many countries. However, 186 countries did not conduct the HepB-BD within 24 hours of 
birth although universal vaccination has been introduced nationwide since 2017[38] .There 
was 79% of the 192 WHO member states adopted policies of universal childhood 
immunization against HBV in 2003[39, 40]. A significant achievement of the associated 
benefit was the decline in the prevalence of neonatal HBV infection and subsequent 
sequelae in Taiwan after the introduction and widespread use of HBV vaccine[41-43]. 
According to CDC, the recommended dose for infants and children younger than 
11 years old are 0.5 mL (5 mcg) of pediatric or adult formulation Recombivax HB (Merck) 
or 0.5 mL (10 mcg) of pediatric Engerix-B (GlaxoSmithKline). The usual schedule is 0, 1 
to 2, and 6 to 18 months with three intramuscular doses of vaccine, but depending on 
individual country and infectious disease prevalence, they will give another suitable 
immunization schedule. Toward mothers have HBsAg positive or unknown HBsAg status, 
their infant will receive the last dose by 6 months of age (12 to 15 months if Comvax is 
used). 
Hepatitis B vaccine and hepatitis B immune globulin (HBIG) within 12 hours of 
birth are suggested for preterm infants whose mother have HBsAg-positive or unknown 
HBsAg status. Although  preterm infants whose weight less than 2000 grams have a lower 
response to hepatitis B vaccine administered before 1 month of age, they are likely to reach 
an adequate response as full-term infants by chronologic age 1 month, regardless of initial 
birth weight or gestational age. Besides, those infants who have mothers are HBsAg 




month. If preterm infants are guaranteed about their stable medical status and gaining 
weight consistently before chronologic age 1 month, they also can receive hepatitis B 
vaccine. The full doses are recommended without divided or reduced doses.  
Vaccination program influenced to the population has been shown in in the WHO 
Western Pacific region, where followed the timebound target with the first deployed HBV 
vaccination programs in the 1980s and 1990s in several countries [44] .All of countries and 
areas of the Western Pacific region had started vaccinating infants by 2005, which 
estimated the number of CHB infection among children born between 1990 and 2014 in 
this region [45] prevented by Hepatitis B vaccine was more than 37 million cases, in result 
averting more than 7 million deaths related to HBV. The percentage of HBV threedose 
vaccination coverage and HBV birthdose coverage were 92.2% and 81.5% respectively in 
2014 [45]. As of 2015, the prevalence of HBsAg primarily decreased from 4.7 % to 1.3% 
in children under 5 years old as an accomplishment of worldwide vaccination programs 
whereas there was no change in this prevalence in nonvaccinated people [46]. Hepatitis B 
vaccine for infants has been used in 186 countries and three doses of HBV vaccine coverage 
was estimated to be 84% by the end of 2016 [27]. 
The vaccination program, which should be flexible and should take into account 
the feasibility of delivering three doses of vaccine to adolescents and adults, has not been 
existing in routinely schedule for this age group. However, unvaccinated adults and 
adolescents should be immunized whenever possible.  High-risk groups are recommended 
for identifying and receiving hepatitis B vaccine including drug users and persons with 
multiple sex partners, hemodialysis patients,hemophiliacs, household and sexual contacts 
of persons infected with HBetcct,…. [18, 47]. There was universal screening for pregnant 
women in 1988 after the defeat in recognizing hepatitis B infected in high risk women [26] 
, though it did not shown the breakthrough impact on reducing HBV infection rate [48]. 
2.1.5.2.2. Immunogenicity and Vaccine Efficacy  
It estimated a greater number of 90% of healthy adults and more than 95% infants,  




responses. Immunogenicity reduces at an age-specific, to be clarified recipients respond to 
a three-dose series around 90%( after 40 years old) and 75% (by 60 years old) respectively.  
For who receives the adequate vaccine series, the range of preventing infection or 
clinical hepatitis is from 80-100%.  
Toward most hemodialysis patients and immunocompromised persons, larger 
vaccine doses (2 to 4 times the normal adult dose), or an increased number of doses, are 
required to induce protective antibody.  
Injection site is also a crucial part in enhancing the vaccine efficacy. The highly 
recommended muscle for hepatitis vaccination in adults and children is deltoid muscle, 
while this site for for infants and neonates is the anterolateral thigh. It indicates the lower 
immunogenicity of vaccine in adults when injections are given in the gluteus. Apart from 
these site, Hepatitis B vaccine should not be counted as valid and should be repeated unless 
serologic testing indicates that an adequate response has been achieved. 
2.2. EPIDEMIOLOGY OF HEPATITIS B IN WORLDWIDE AND VIETNAM 
2.2.1. Epidemiology of hepatitis B in worldwide 
Hepatitis B is considered as an important issue for many countries worldwide in 
the light of its consequence to human’s health and significant effects to social economy 
with high treatment cost. HBV- related deaths was booming from 0,89 to 1,45 million just 
in two decades starting from 1990[49]. The number of deaths from viral hepatitis was 1,32 
million(2015) due to its complications accounted for 96%, quite equal to this figure in 
tuberculosis(1,37 million) and higher than HIV infection (1,06 million) and malaria (0,55 
million). HBV is responsible for the majority problem 1,34 millions viral hepatitis deaths, 
at 66%[46]. According to WHO, 887.000 deaths (2015) from HBV mainly caused by 
complications as cirrhosis and hepatocellular carcinoma [50].  
Globally, HBV concentrated in Africa and Asia -Pacific regions, parts of the 
Middle East and the Amazon Basin, 8-15% of the population carry HBV with over 60% 




at birth or during early childhood. The rate of chronic liver diseases among adults are very 
high but the acute HBV – related disease is rarely because of asymptomatic of infection 
[18, 32].  In Asia, the  prevalence of HBsAg were high or high intermediate in general 
population in Vietnam, Mongolia, Laos, China, the Philippines, South Korea, Singapore 
and Cambodia[2]. China’s report following a national serological survey in 1992 indicated 
the prevalence of HBsAg in total residences was 9,75%[51], which the majority 
transmission were mother to child and other non-parental exposure during early childhood 
[52]. 181.826 prenatal infections was estimated in this region in 2014, in which 90% out of 
this figure was diagnosed chronic, in particularly 35%  (63,709 cases) occurred in China, 
33% (60,753 cases) occurred in the Philippines, 23% (42,363 cases) occurred in Viet Nam, 
and 4% (6804 cases) occurred in Papua New Guinea [45]. It was also estimated more than 
300 thousand deaths per year in the Western Pacific Region in 2017 [53] and stood in the 
highest position in the prevalence of HBsAg (6,2%) comparing to others continents, which 
included nearly 50% people with chronic hepatitis B infection globally [46, 54].  
Whereas, this figure in Europe and the Americas experienced a lower chronic HBV 
carrier prevalence from 0.1-0.5% in general population, with lifetime risk of HBV infection 
less than 20%, basically concentrate on adulthood [18, 32]. Annually in America, the 
number of patients’ deaths in light of hepatitis B-related cirrhosis and hepatitis B-related 
liver cancer are 3,000 to 4,000 and 1,000 to 1,500 respectively [18]. Although, Europe and 
the Americas experience the lower prevalence of HBsAg, this figure does not describe 
exactly contribution equally among areas and ethnic groups, mostly prevalent in the 
African and Asian immigrants, or their regular residence. Moreover, those certain groups 
may transmit to other indigenous population groups through sexual contacts such as men 
who have sex with men, persons with multiple sex partners and injecting drug users. Thus, 
making quality and accurate assessment of the national prevalence is much more 
challenging [49]. 
Until now, there is no specific treatment for hepatitis B and the number of people 




proportion of HBV- related morbidity and mortality, its consequence as well as block the 
dramatic spreading out of HBV infection worldwide is prevention. Hepatitis B 
immunization has deployed popularly in every regions to fulfill this intervention mission. 
Borne-blood transmission can be reduced completely by the birth dose vaccination, 
intravenous hepatitis B immunoglobulin, and peripartum antiviral therapy for mothers with 
high viral load [55, 56]. Besides, potentially effect of hepB-BD also helps newborns out of 
the HBV infections [57]. 
There were many remarkable achievements in hepatitis B immunization program. 
According to Weisen et al’s study, before hepatitis B immunization program, chronic HBV 
infections accounted for greater than 8% in most of countries and plummeted to less than 
1% in most countries in Western Pacific Region by 2014. In the period of 10 years since 
2000, the number of the 3rd dose of HBV immunization and HepB-BD went up 
dramatically and became stable in the past decade. It showed the decrease in the prevalence 
of chronic HBV infections among babies annually (~37.595.665 cases) between 1990 and 
2014 by vaccination program. The statistic reported 92.2% HepB3 coverage and 81.5% 
HepB-BD coverage on average with 2.999.996 chronic infections and 570.566 deaths 
would have occurred in their lifetime were averted in 2014. However, a few countries in 
this region should exert themselves in reducing the prevalence of HBV among children 
while this figure still stood at over 3%[45]. South Korea experienced the extremely terrible 
past of HBV- related diseases. The prevalence of HBsAg in young generation was high, at 
4-5% in the years of 70s and early 80s [58, 59]. Fortunately, this figure went down 
significantly when government applied initially vaccination program in Korea by 1985; 
from 3.2% (1988) to 2.6%(1993) [60], continued to drop to under 1%(1995) [61] and 
reached at 0.2% (2006)(KCDC, 2009). The prevalence of positive HBsAg results also have 
experienced a strongly decline in 20 years since 1986 in men and women, (8.3%,  6.9% 
respectively)(KDCD, 2012)[62].  Sharing the similar great results after implement the mass 
of HB vaccination in Russia, the number of AHB cases reduced 33 times from 43.8 to 1.3 




In general, hepatitis B vaccination plays a core role and priority choice for public 
health, though HBV infection is still a burden to many countries, especially for endemic 
areas such as Asia and Africa.  
2.2.2. Epidemiology and Immunization program of Hepatitis B in Vietnam 
According to General Statistics Office of Vietnam – 2015, the average population 
of Vietnam was approximately 83.83 million and the density was 252 persons /km2 [64], 
in which around 8.4 million people lived with chronic HBV and 23.300 HBV-related deaths 
[65]. There was a high chance of positive HBsAg in community, from 15-20% in a large 
of areas in Vietnam [8, 12, 66-69]. The proportion of Hepatitis B birth dose is only 74% 
coverage[70]. There is greater than 8% of Vietnamese population has HBV and 90% 
children are infected from their mother who has positivity of HBV.  In average, one in four 
adults who acquire this disease as children die of health problems such as cancer liver[71]. 
The study conducted by Van Nguyen et al. in 2010 reported the highest prevalence 
experienced in age group of 30 to 39 years in both genders (19.3% for male and 14.0% for 
female) followed by age group of 40-49 years old (18.6% and 13.4%, respectively) [13]. 
The amount of HBV exposure accounted for a half in the teenagers (16–19 years), although 
increasing with age in Van Thi et al. studying in 837 participants of two rural districts in 
Thai Binh, 2007 [8]. 
Although vertical transmission is considered common in high endemic nations like 
Vietnam, horizontal transmission also plays an important role in spreading HBV, specific 
from mother to children. The prevalence of HBsAg in children was from 9.3% to 
14.1%,suggested that perinatal and early childhood [13]. Every year, an estimated 54,600 
children have chronic hepatitis B if they do not vaccinate in 24 hours after delivery, who 
become the important source of infection in community. Around 20-30% children of this 
figure (~11.000-16.000 children) would evolve in liver cancer and cirrhosis [66]. 
Furthermore, Vietnam also experiences difficulty from reality conditions like hard 
approaching areas (mountain, island,etc…), lack of finance for health care, behavior and 




children in Vietnam through his study in 6949 children, which reported overall HBsAg 
prevalence in target participants was 2,7% (95% CI= 2,20-3,30). This figure was higher in 
children born at home (5,47%)compared to those born in facilities (2,25%)(PR= 2,43 95% 
CI=1,68-3,51). Children of other ethnicity had higher HBsAg prevalence than Kinh 
ethnicity (5,36%, 2,16% respectively) (PR: 2.48, CI: 1.71–3.58) [72]. 
Hepatitis B virus vaccine is highly priority option for preventing both perinatally 
and horizontally acquired chronic HBV infection [73-75]. Since 1997, hepatitis B vaccine 
has been started to utilize in selected areas, then infant hepatitis B vaccine was expanded 
nationwide in Expanded Program on Immunization in 2002 with an average of 4,5 million 
doses annually. With the financial support from GAVI Alliance, a monovalent hepatitis B 
vaccine birth dose was introduced in 2003. Initially, hepatitis B vaccine was recommended 
to be given within 7 days after birth and changed into 3 days after birth, 24 hours after birth 
in 2002 and 2006 respectively. The birth dose was given at health facilities only.  In June 
of 2010, subsequent hepatitis B doses are given as part of a pentavalent DPT-Hib-Hepatitis 
B vaccine was deployed in children under one year old, which made the number of hepatitis 
B doses reduced to 1,5 million and just only used for neonatal period since 2010. Caregivers 
were requested to bring their child to commune health center and outreach points (for hard 
to reach areas only) for vaccination[66, 72]. 
Vietnam shares the similar fundamental routes of HBV transmission toward other 
countries in South East and Eastern Asia, are from mother-to-child or from close contacts 
during early childhood[76]. In collaboration with Ministry of Health, Provincial 
Department of Health and WHO, Expanded Program implemented with potential effort and 
determination in order to reduce the mortality of transmission from mother to children in 
maternal period, enhance the percentage of hepatitis immunization is B vaccine for infant 
in 24 hours after delivery. There was a significant climb in three-dose hepatitis B vaccine 
coverage from 24% in 2000 to >90% yearly starting 2004. However, this figure 
experienced a fall dramatically  to 29% in 2007 and 26% in 2008 due to media reports of 




Health Organization’s Western Pacific Regional meeting in 2012, Vietnam achieved the 
goal of declining percentage of chronic HBV under 2% in children of 5 years old [66].  
Overall, the enlarge of hepatitis B vaccine and accomplishment that EPI had got 
before, though hepatitis B in Vietnam still remained a serious problem in community health 
and could be a burden in the future. Vietnam is conquering to decline the prevalence of 
HBV infection with well policy and effort in immunization program.  
2.3. CHARACTERISTICS ABOUT STUDY PARTICIPANTS 
Quang Ngai, Binh Dinh, Khanh Hoa and Ninh Thuan are all located in central 
region of Vietnam, which is a component of three main regions in Viet Nam. It  has 15 
coastal  provinces and 5 mountainous provinces, connected the southern and northern of 
nation. For many decades, those provinces have suffered from natural disasters, obstacles 
and difficult of access geography, lack of propitious conditions,etc… for developing 
themselves. However, with a new policy from government through “Doi moi” period as 
well as strong self-reliant and taking advantage of province’s human and natural resources, 
those provinces have recent got a very fast, stable, and equitable economic growth to date. 
They concentrate on exploiting tourism along the coast, seaports, industrial zones, export 
processing zones and transportation. The traditional of agriculture, fishery, handicrafts 
have interlocking and supporting activities. As the front of the Mekong sub-region, from 
here it is possible to trade with countries such as Laos, Cambodia, Thailand, Myanmar and 
further to South Asian countries and southwestern China through the axis of the East-West 
corridor, Highway 9, Road 14, Road 24, Road 19. These economic areas not only play a 
role in driving the socio-economic development of the region but also in the socio-
economic development strategy, country geography, economy, politics, culture and 
national security[79]. 
Despite the fact that the recent economic growth is potential, central region faces 
the challenge of further problems, especially health issues are always considered. 
Comparing to two other regions, central region is considered as a complicated region in 




with other neighbor countries. It still remains the large amount of people living in 
disadvantage area, especially ethnic minorities who neither have a right health seeking 
behavior nor chance to approach health system and EPI regularly. Besides, patient’s 
demand for health care service and utilization have changed based on their own income 
and the dramatic modification in policies in health sector in Vietnam, which may relate to 
infant vaccination program.   
Overall,  EPI in general and hepatitis B vaccine in specific is a topic of universal 
interest, approaching immunization helps governors, community’s leader and health 
manager have a well-round outlook of the current situation aiming to improve not only the 
















CHAPTER 3  
METHOD AND MATERIALS 
3.1. STUDY DESIGN 
This is a secondary analysis of a population- based, cross-sectional seroprevalence 
survey, which cooperated between Pasteur Institute Nha Trang and National Center of 
Global Health and Medicine (NCGM) during June to July in 2019 at the four provinces 
(Khanh Hoa, Ninh Thuan, Binh Dinh, Quang Ngai) in Vietnam. Data source was received 
using approval from two aforementioned organizations for conducting.  
3.2. METHODOLOGY 
3.2.1. Population and Sample size 
The residence lived in four provinces (Khanh Hoa, Ninh Thuan, Binh Dinh, Quang 
Ngai) were chosen randomly and agreed to participate in study. This representative cross-
sectional survey sampled population based on a stratified four-stage cluster design. 
Demographic and vaccination data were collected along with a whole blood specimen that 
was collected and interpreted in the field with a point-of-care HBsAg test. We estimated 
the seroprevalence by age group for every 5 years old. The required sample size was 
calculated by WHO’s samples size calculator.  
(http://www.who.int/chp/steps/resources/sampling/en/) 
The sample size of 240 for each age group was calculated based on the expected 
seroprevalence of 50% (to maximize the size) with a 5% level of significance and a 
precision of 10.0%. The design effect for cluster sampling was assumed to be 2.0 with a 
response rate of 80%. The sample size of 1200 households was calculated based on the 
population pyramid and average number of household members in Vietnam to cover 240 
in each group. 
 Population in Vietnam (2014): 90,730,000 
 Household in Vietnam (2014): 26,700,000 




 # of households to be visited: 1200 
 # of members visited (expectation): 1200 * 3.4 = 4080 
 # of members visited by age group  
Figure 3. Participants distribution 
Age 
group 
Rate(%) # Cumulative Age 
group 
Rate(%) # Cumulative 
0-4* 8.01 327* 327 40-44 6.57 291 2885 
5-9 7.86 321 649 45-49 5.92 268 3153 
10-14 7.18 293 942 50-54 5.25 242 3395 
15-19 6.80 277 1219 55-59 4.16 214 3609 
20-24 7.95 324 1543 60-64 2.66 170 3779 
25-29 9.25 377 1920 65-69 1.52 108 3887 
30-34 8.67 354 2274 70-74 1.17 62 3949 
35-39 7.84 320 2594 >75 2.06 129 4078 
    Total 100.00 4078  
* for 1-4 years old, # will be 261 (= 327 * 4/5) 
 Expected Total # to be visited (from 1 to 39 y.o.): 2528   (= 2594 – 327 +261) 
3.2.2. Sampling method 
Collected samples from representative population were aged 1 year old to adults 
less than 40 years. They were selected by 4 stages probability proportional to size (PPS) 
sampling. Provinces considered as strata, yielding a total of four strata.  
In the first stage of sampling, three districts were selected randomly from each stratum 
using probability-proportional-to-size (PPS) based on the population data. 
In the second stage, two communes were selected randomly from each selected district by 




In the third stage, two villages were selected randomly from each selected commune by 
PPS, and a total of 48 villages, as clusters, were selected. 
In the fourth stage, 25 households were selected randomly from each selected village, and 
a total of 1200 households were selected. 
All the members from 1 to 39 years old in each selected household were included into the 
survey. When the number of collected sample in 1 village reach to 54 (= 2594 / 48), the 
survey team stopped data collection at the village. 
Figure 4. Distribution of sample size collecting 
Age group Sample size(n) Age group 
Sample size(n) 
1-4 292 20-24 
169 
5-9 358 25-29 
236 
10-14 310 30-34 
238 




(*) Data was collected from 2093 participants, which had:  
12 were excluded for analysis (6 are 0, 4 are 40 years old and 2 are of unknown age) 
6 were excluded for analysis (no HBsAg testing or unknown results) 
3.3.  STUDY LOCATIONS AND STUDY PERIOD 
3.3.1. Study location 
48 villages (24 communes) in four provinces (Khanh Hoa, Ninh Thuan, Binh Dinh, 
Quang Ngai)  
3.3.2. Data collection period:  From June to July 2019  
3.3.3. Data collection method 







The structured questionnaires were prepared before the field survey. Toward 
participants under 18 years old, their parents or caretaker was responsible for complete the 
questionnaire. Information was collected on the demographic status and immunization 
history, socioeconomic status of the household as well as the behavior seeking for 
healthcare service. Questions regarding potential factors for acquiring and treating hepatitis 
B (e.g., family history, barrier to access the treatment) were added. Questionnaire divided 
into 3 main components: demographic for every participants; historical vaccination and for 
≥ 18 years old participants. The household survey interviewed the respondents to collect 
information about the socio-demographic characteristics of the households and also 
detailed information about episodes of illness and the use of healthcare services of each 
family member recently.  
HBV kit test  
The blood specimens (approximately 50 mL) was collected by finger prick and was 
tested in the field using the Alere DetermineTM HBsAg point-of-care test strip (reported 
sensitivity: 95–100%; reported specificity: 96–100%)[80-82]. Eluates were tested for 
HBsAg using a chemiluminescent microparticle immunoassay (Architect i2000SR; Abbott 
Diagnostics, IL, USA). The relative light unit (RLU) value of each sample was detected 
with an automated system. The sample was considered to be positive for HBsAg based on 
comparisons to the RLU value of a calibration sample. 
3.3.3.2. Data collection technique 
Step 1: Chose health staff who get familiar with collecting data for scientific study and 
technicians who were trained blood taking. 
Step 2: Surveyors were trained about asking questionnaire, observation in data collection 






Step 3: Trial survey 
Chose randomly 10 people from two health care centers and conducted trial survey. After 
trial survey, evaluated the average of time for interview and finished the questionnaire, 
changing those of inappropriate questions based on reality residence conditions, capacity 
of understanding and answering from participants.  
Step 4: Collecting data 
Surveyors explained the objectives of study and interview participants, followed the 
questions. Participants had to read sign in consent form. Participants answered 
questionnaire must be above 18 years old. For who was under 18 years old, their mother, 
father or guardian helped them answer the questionnaire. After answered questionnaire, 
participants continued to take blood and receive the result of HBsAg and gifts before leave.  
Survey team 
Twelve survey teams were formed, and each team was comprised of three members 
including a health staff from PINT and two surveyors nominated from the district health 
staff. Each team covered 1 selected district (2 communes, 4 villages).  
Supervisor team  
There was a supervisor team in each province, and each team was comprised of 
three members including a health staff from PINT and two health staff from the Provincial 
Control Disease Center. They mornitored in the study area in indicated province.  
Village collaborator  
Village collaborators were in charge of sending invitation card to select households 
in villages based on the random household list. The selected households were informed in 






3.3.4. Conceptional framework 
 
Figure 5. Conceptual Framework 
3.3.5. Variables and quantification  
3.3.5.1. Demographic and socio-economic factors 
For every participants 
- Age: divided into 2 age-groups (<18 years old and ≥ 18 years old) 
- Gender: divided into 2 groups (female and male) 




- Length of traveling time between house and health center: divided into 4 groups (<15 
minutes; ≥15 minutes- <30minutes; ≥30 minutes) 
- Transportation (using for go to healthcare center) divided into 5 groups (walking on foot, 
by bicycle, by motorbike, by car, others) 
- Place of giving birth: divided into 7 groups (Hospital; Health center; Health station; 
Private clinical; House; Paddy Field, Garden, farm; Others)  
- Attendant for delivery: divided into 6 groups (Medical staff; Village health volunteer; 
Traditional Birth Attendant; Family member & Relatives; By mother herself; Others) 
- Reason for choosing this delivery place: opening question 
- Vaccination history: divided into 3 groups (Yes, No, Unknown) 
- Vaccination site: divided into 5 groups (Hospital, Health center, Health station, Outreach 
of commune site, Private doctor, Others) 
- Availability of immunization card: divided into 2 groups (Yes, No) 
For ≥ 18 years old participants  
- Educational level: divided into 3 groups (Low (None; Primary school; Junior high 
school); Medium (High school); High (College /university or above; Others)) 
- Career: divided into 8 groups (Government and Public officer; Farmer/Fisher; Labor/work 
for factory; Housework, Freelancer; Company worker; Merchant; Others) 
- Individual income: divided into 4 groups (>50.000.000 vnd; <50.000.000 vnd & 
>25.000.000 vnd; <25.000.000 vnd; Not prefer to answer) 
- Way to approaching immunization schedule: divided into 10 groups (Medical staff; 
Village health volunteer; Vaccination bulletin; Brothers/sisters or friends; Radio / TV; 
Poster; Village head man/ Unit village head; Women’s union told you; Others; Unknown) 
- Person make vaccination decision: divided into 6 groups (Father; Mother; Both mother 




- Way to approaching immunization day for your children: divided into 11 groups (Medical 
staff; Village health volunteer; Immunization card; Brothers/sisters or friends; Radio / TV; 
Poster; Local authority; Women’s union; Megaphone; Invitation from district manager; 
Others) 
- Intended place for next pregnancy: divided into 7 groups (Hospital; Health center; Health 
station; Private clinic; House; Farm, garden and forest; Other place) 
- Consultant for health problem: divided into 7 groups (Husband/wife; Other family 
members; Medical staff; Village health volunteer; Local authority; Friends / neighbors; 
Other) 
- Refusing health care service due to financial condition: divided into 3 groups (Yes, No, 
No health problem) 
- Health care service refusing due to financial condition: divided into 9 groups (Maternal 
and childcare; Immunization; Malaria; Tuberculosis; Hypertension; Diabetes; Cancer; 
Rehabilitation; Others) 
- Refusing health care service due to hospital condition and or skill health staff: divided 
into 3 groups (Yes, No, No health problem) 
- Health care service refusing due to hospital condition and or skill health staff: divided 
into 9 groups (Maternal and childcare; Immunization; Malaria; Tuberculosis; 
Hypertension; Diabetes; Cancer; Rehabilitation; Others) 
- Blood transfusion: divided into 3 groups (Yes, No, Unknown) 
- Tatoo: divided into 2 groups (Yes, No) 
- Frequency of surgical operation: divided into 4 groups (Never, Once, Twice or more; 
Unknown) 
- Family member have Hepatitis B: divided into 3 groups (Yes, No, Unknown) 




- Neonatal Hepatitis B dose (0-24hours)  
- DPT-Hep B+Hib (dose 1,2,3) 
3.4. ANALYTICAL METHODS  
- The data was checked before entry in Excel. Data entry for HBsAg and questionnaire will 
be conducted in the PINT. Brief analysis was done in NCGM and discussed among PINT, 
NCGM.  
- Data processing is coded, and statistic by SPSS 25.0.  
- The categorical data was reported as number and percentage. 
- Data analysis was undertaken using chi square tests and multiple logistic regression 
model. 
3.5. ETHICS STUDY 
Study conducted collecting primary data underwent an IRB approval and ethical 
review with the research proposal from PINT, NCGM. Secondary data is used in this thesis 
after receiving approval from ethical Council of Yonsei University Health System, under 
the agreement of PINT and NCGM. 
Participants are asked to sign on the consent form after informing them of the freedom 
of decline and other rights in a non-coercive environment.  
If participants are less than 18 years old, the consents are obtained from their parents 
or caregivers.  
Dataset that involves the individual name (anonymous), address and other results 




CHAPTER 4  
RESULTS 
4.1. DEMOGRAPHIC CHARACTERISTICS OF RESEARCH PARTICIPANTS IN 
CENTRAL REGION OF VIETNAM 
Table 1: General demographic characteristics of research participants in 
Central region of Vietnam 
Variables 
≥ 18 years old 
(n= 956) 
< 18 years old 
(n= 1119) 












N % N % N % 
Mean of Age  
(Mean ± 𝑆𝐷) 
29.66 ± 6.107 8.87±4.726 18.45± 11.69 
Gender 
Male 253 29 11.46% 553 10 1.81% 806 39 
4.83% 
Female 703 58 8.25% 566 15 2.65% 1269 73 
5.75% 
Province 
Khanh Hoa 278 25 8.99% 255 5 1.96% 533 30 
5.62% 
Ninh Thuan 256 30 11.72% 270 5 1.85% 526 35 
6.65% 
Quang Ngai 226 16 7.08% 297 7 2.36% 523 23 
4.4% 
Binh Dinh 196 16 8.16% 297 8 2.69% 493 24 
4.87% 
Level of Education 
Low 520 46 8.85% 
- -  - -  
Medium 237 24 10.13% 
- -  - -  
High 181 17 9.39% 
- -  - -  
Others 18 0 0 












60 7 11.67% - -  - -  
Company worker 20 1 5.00% - -  - - 
 
Merchant 107 10 9.35% - -  - - 
 
Housework 106 10 9.43% - -  - - 
 
Freelancer 77 2 2.60% - -  - - 
 
Others 119 11 9.24% - -  - - 
 
Annual Income 
≥50.000.000 vnd 230 24 10.43% - - 
 - -  
< 50.000.000 vnd & 
≥25.000.000 vnd 
190 16 8.42% - - 
 
- -  
<25.000.000 vnd 198 16 8.08% - - 
 - -  
Not prefer to 
answer 
338 31 9.17% - - 
 
- -  
(-): not applicable 
The number of participants in the survey was 2,075 participants, which were 
divided into 2 age groups: ≥ 18 years old (n= 956; 46.1%) and <18 years old (n= 1119; 
53.9%). The number of females was higher than males in group ≥ 18 years old, and this 
figure was equal in the group <18 years old. The total proportion of HBsAg (+) was (n=112; 
~ 5.4%), in which the ≥ 18 years old (9.1%) and <18 years old (2.23%). This figure of male 
was well- above higher than female, at 11.46% and 8.25% respectively in group ≥ 18 years 
old; but this figure was reversely with male: 1.18% and female: 2.65% respectively in group 
<18 years old.  
The sample of participants distributed quite similarly in 4 selected provinces. Ninh 
Thuan province reached the highest positive HBsAg(+) cases (group ≥ 18 years old 
:11.72%; group <18 years old: 1.85% ) out of 4 selected provinces at two age-groups, 
followed by Khanh Hoa and Binh Dinh with a quite similar proportion of HBsAg(+) in two 




old :8.16%; group <18 years old: 2.69%) respectively. Quang Ngai shared the smallest 
proportion of HBsAg (+), around (group ≥ 18 years old: 7.08%; group <18 years old: 
2.36%).  
Most of participants ≥ 18 years old had low level of education, though the highest 
HbsAg (+) percentage was the most prominent in medium education level (high school) 
(n= 24;10.13%), high level education (college and above) (n=17; 9.39%), low level of 
education (none, primary school and junior high school) (n=46; 8.85%) and others was not 
significant.  
The popular career in selected participants were farmer/fisherman (35.9%); 
government and public officer (12.9%); merchant (11.2%); housework (11.1%). The 
prevalence of HBsAg (+) was the most prominent in labor/work for factory (n=7;11.67%), 
followed by the government and public officer (n=13; 10.57%), the proportion of HBsAg 
(+) from others popular sectors such as farmer/fisherman, merchant, housework tied at 
roughly in the range from 9.24-9.59%; lower cases in groups of company worker (n=1,5%) 
and freelancer (n=2, 2.6%).  
On average, the annual income for each household are range from under 25 million 
VND to over 50 million VND and there was no big gap percentage difference participants 
among those groups (≥50.000.000 vnd: 24%; < 50.000.000 vnd & ≥25.000.000 
vnd:19.87%; <25.000.000 vnd:  20.7%). However, the number of people not prefer to 
answer was quite high (33.2%). The significant HBsAg (+) percentage ≥50.000.000 vnd 
group (n=24; 10.43%), followed by the groups had no respond, while the percentage of 
other groups were quite similar (<50.000.00 and ≥25.000.000 vnd n= 16; 8.42%; 






4.2. ENVIRONMENTAL FACTORS AFFECT TO USING HEALTH CARE 
SERVICES OF PARTICIPANTS IN CENTRAL REGION, VIETNAM  
Table 2: Percentage of HBsAg (+) according to the accessibility to health facility 
Variables 
≥18 years old 
(n= 956) 
< 18 years old 
(n= 1119) 








N % N % N % 
Main transportation to the nearest health facility 
On foot 65 5 7.69% 85 5 5.88% 150 10 
6.67% 
Bicycle 31 0 0 66 0 0 97 0 
0 
Motorbike 852 82 9.62% 954 20 2.10% 1806 102 
5.65% 
Car 5 0 0 4 0 0 9 0 
0 
Others 3 0 0 10 0 0 13 0 
0 
Time to nearest health facility 




49 3 6.12% 90 1 1.11% 139 4 2.88% 
≥30 minutes 38 4 10.53% 33 2 6.06% 71 6 
8.45% 
(-): not applicable 
Residents tend to use the motorbike (87.04%) as a priority transportation to 
approach the nearest health facility, the second way was go on foot (7.2%). The other 
vehicle (bicycle, car, electric bicycle) was not popular use. The prevalence of HBsAg (+) 
was highest in group using motorbike (≥ 18 years old: n=82; 9.62% and <18 years old n= 
20; 2.1% and in on foot group this prevalence (≥ 18 years old: n=5; 7.69 %) and <18 years 
old (n= 5; 5.88%), other groups has no positive cases. 
The distance between their house and health facility taking mostly under 15 




HBsAg (+) in both age groups in the participants approach to health facilities over 30 
minutes (≥ 18 years old: n=4, 10.53%) and <18 years old: n=2, 6.6%).  
Table 3: Percentage of HBsAg (+) according to the health services 
Variables 
≥18 years old 
(n= 956) 
< 18 years old 
(n= 1119) 








N % N % N % 
Place of giving birth    
Hospital 297 26 8.75% 755 11 1.46% 1052 37 3.52% 
Health center 78 6 7.69% 121 1 0.83% 199 7 3.52% 
Health station 181 16 8.84% 89 5 5.62% 270 21 7.78% 
Private clinical 12 1 8.33% 27 0 0 39 1 2.56% 
House 351 37 10.54% 125 7 5.60% 476 44 9.24% 
Paddy Field, 
Garden, farm 
0 0 - 0 0 - 0 0 - 
Others 37 1 2.70% 2 1 50.00% 39 2 5.13% 
Attendant for delivery    
Medical staff 572 52 9.09% 987 16 1.62% 1559 68 4.36% 
Village health 
volunteer 
6 0 0 7 0 0 13 0 0 
Traditional Birth 
Attendant 
281 26 9.25% 89 7 7.87% 370 33 8.92% 
Family member & 
Relatives 
103 13 12.62% 72 3 4.17% 175 16 9.14% 
By mother herself 9 1 11.11% 0 0 - 9 1 11.11% 
Others (unknown) 46 3 6.52% 4 1 25.00% 50 7 14% 
Reason for choosing this delivery place    
Complicated case 21 4 19.05% 114 2 1.75% 135 6 4.44% 




Effortless delivery 26 2 7.69% 34 1 2.94% 60 3 5% 
Financial and 
external condition 
97 13 13.40% 42 4 9.52% 139 17 12.23% 
Individual 
selection 
101 14 13.86% 68 4 5.88% 169 18 10.65% 
Mother and child 
safety 




68 4 5.88% 86 1 1.16% 154 5 3.25% 
Unknown 172 9 5.23% 35 3 8.57% 205 12 5.85% 
Using health facilities for delivery was the top noteworthy considered option  for 
both age-groups (hospital: 50.3%, health station: 13%, health center: 9.6% ), while the 
percentage of  having birth at home still existed (22.9%). The prevalence of HBsAg (+) 
was dramatical evaluated in ≥ 18 years old group comparing to the <18 years old group, 
which the highest in delivery in house in ≥ 18 years old group (≥ 18 years old: n=37, 10.54 
% and <18 years old: n=7; 5.6%), followed by health station (≥ 18 years old: n=16, 8.84 % 
and <18 years old n= 5; 5.62%), and hospital (≥ 18 years old: n=26, 8.75 %) and <18 years 
old: n=11; 1.46%).  
Most of attendant for delivery for both age-groups are health staff such as medical 
staff (75.2%); traditional birth attendant (17.8%) and family members & relatives (8.4%). 
However, the prevalence of HBsAg (+) in family members & relatives sector (≥ 18 years 
old: n=13; 12.62% and <18 years old: n=3; 4.17%) was the highest, then mother herself 
sector (≥ 18 years old: n=1; 11.11%); group having traditional birth attendant (≥ 18 years 
old: n=26; 9.25%) and <18 years old n=7; 7.87%), medical staff attendant (≥ 18 years old: 
n=52; 9.09%) and <18 years old: n=16; 1.62%).  
Convenience (≥ 18 years old: n=218 and <18 years old: n=185) and Mother and 




for delivery places in both age-groups. In complicated case sectors, the prevalence of 
HBsAg (+) in ≥ 18 years old age-group was the highest (n=4; 19.05%). Financial and 
external condition considered as an relevant reason to delivery place decision in both age 
groups, which was one of those sectors had high prevalence of HBsAg (+) (≥ 18 years old: 
n=97, HBsAg (+): n=13, 13.4%) and <18 years old n=42; HBsAg (+): n=4, 9.52%). 
     Table 4:Percentage of HBsAg (+) according to the Hepatitis B infection risks 
Variables 
≥18 years old 
(n= 956) 






N % N % 
Blood transfusion 
Yes 45 9 20.00% - -  
No 880 78 8.86% - -  
Do not know 31 0 0 - -  
Tattoo 
Yes 59 4 6.78% - -  
No 897 83 9.25% - -  
Frequency of surgical operation 
Never 682 62 9.09% - -  
Once 164 15 9.15% - -  
Twice or more 85 9 10.59% - -  
Do not know 25 1 4.00% - -  
Family member have Hepatitis B 
Yes 92 28 30.43% - -  
No 642 36 5.61% - -  
Do not know 222 23 10.36% - -  




Blood transfusion did not exist in many ≥ 18 years old participants (n=880; 92.5%), 
though the prevalence of HBsAg (+) in group having blood transfusion was higher 2.26 
times comparing to group having no blood transfusion. Reversely, it shares the different 
trend as ≥ 18 years old participants group having no tattoo with (n=897; 93.8%) but its 
prevalence of HBsAg (+) was higher comparing to group having tattoo (9.25%, 6.78% 
respectively).  
The proportion of population never has surgical operation (n=682; 71.6%). The 
prevalence of HBsAg (+) was higher progressively as the increasing of the number of 
surgical operation times (never: n=62; 9.09%; once: n=15; 9.15%; twice or more: n= 9; 
10.59%). 
Mostly, people had no family members having Hepatitis B and the prevalence of 
HBsAg (+) was the higher in participants group having Hepatitis B (n=28; 30.43%), as 5.4 
times comparing to the group have no Hepatitis B (n=36; 5.61%), However, the positive 
status of HBV infection in group do not know their family status was significantly (n=23; 
10.36%).  
Table 5:Percentage of HBsAg (+) according to the vaccination behaviors 
Variables 
≥18 years old 
(n= 956) 
< 18 years old 
(n= 1119) 








N % N % N % 
Vaccination history 
Yes 634 50 7.89% 1066 23 2.16% 1700 73 4.29% 
No 212 32 15.09% 20 2 10.00% 232 34 14.66% 
Unknown 110 5 4.55% 33 0 0 143 5 3.50% 
Vaccination site 
Hospital 32 2 6.25% 144 1 0.69% 176 3 1.70% 




Health station 552 44 7.97% 981 21 2.14% 1533 65 4.24% 
Outreach of 
commune site 
42 2 4.76% 50 2 4.00% 92 4 4.35% 
Private doctor/clinic 16 1 6.25% 5 0 0 21 1 4.76% 
Others 17 1 5.88% 4 0 0 21 1 4.76% 
Availability of immunization cards 
Yes 5 0 0 285 6 2.11% 290 6 2.07% 
No 951 87 9.15% 834 19 2.28% 1785 106 5.94% 
(-): not applicable 
In both age-groups, most of participants have historical of vaccination. The 
prevalence of HBsAg (+) in participants have no historical vaccination in group ≥18 years 
old (n=32, 15.09%) was higher than group <18 years old(n=2,10%); and this prevalence 
was higher as well above twice comparing to group having historical of vaccination (≥ 18 
years old: n=50, 7.89%;  <18 years old: n=23, 2.16%).  
Health station was the most popular place for vaccination out of options (73.1%), 
followed with hospital (8.5%) for both age groups. The prevalence of HBsAg (+) in health 
center was the highest (≥ 18 years old: n=6, 12%); <18 years old: n=1, 2.17%); but the 
second position was in health station (≥ 18 years old: n=44, 7.97%; <18 years old: n=21, 
2.14%); hospital had the proportion of positive cases (≥ 18 years old: 2, 6.25%; <18 years 
old: n=1, 0.69%).  
The numerous absence of their immunization card (86.7%) in both age-groups, 
which the prevalence of HBsAg (+) in this group was (≥ 18 years old: n=87, 9.15%; 9 times 
higher compare to group having immunization card; <18 years old:n=19, 2.28%; quite 






Table 6: Hepatitis B doses distribution among participants from 12-48 months old in 
Central Region Vietnam. 
Variables 













N % N % N % 
Hepatitis B dose 0 
(Birth dose) 
96 1 1.04% 17 0 0 151 3 1.99% 
Hepatitis B dose 1 70 1 1.43% 97 2 2.06% 98 1 1.02% 
Hepatitis B dose 2 132 2 1.52% 32 1 3.13% 100 1 1% 
Hepatitis B dose 3 109 1 0.92% 53 2 3.77% 102 1 0.98% 
 
Proper time immunization doses tended to increase, especially in Hepatitis B dose 2 
(n=132, 50%) and Hep 3 (n=109, 41.28%). However, the number of those having no 
immunization is still high dramatically, range from 37-57%. The prevalence of HBsAg (+) 
was increasing gradually in improper time immunization group (0%-3.77%) and remained 
quite steady in both groups: proper time immunization (0.92%-1.52%) and no 
immunization (0.98%- 1.99%) respectively.  
The number of infants having vaccination was low, at n=96, 36.3%. The 
prevalence of HBsAg(+) of children having birth dose accounted for 1.04%, which was 
lower than those did not have birth dose, at 1.99%. Among 4 Hepatitis B doses, Hepatitis B 
dose 1 got lowest proportion in 2 sectors: proper time immunization (26.5%); no 
immunization (37.1%) but highest in improper time immunization sector (36.7%). Hepatitis 
B dose 2 and Hepatitis B dose 3 shared the resemblance trend of growing proper time 




Table 7: Prevalence of HBsAg (+) according to vaccination status among 12-48 
months old infants and toddlers in Central Region Vietnam. 
Variables 




Adequate and proper time 28 0 0 
Inadequate and (or) improper time 137 3 2.19% 
No vaccination 99 1 1.01% 
 
There had no HBsAg (+) among 28 children having adequate and proper time. There were 
3 cases with HBsAg (+) in improper time and (or) inadequate vaccination group (2.19%) 
and this figure in group with no vaccination at 1.01%.  
4.3. ATTITUDE FACTORS AFFECTS TO USING HEALTH CARE SERVICES OF 
PARTICIPANTS IN CENTRAL REGION, VIETNAM  
Table 8: Percentage of HBsAg (+) according to the intended delivery place for 
next pregnancy and consultant for health problem. 
Variables 





N % N % 
Intended place for next pregnancy 
Hospital 539 51 9.46% - -  
Health center 38 2 5.26% - -  
Health station 72 7 9.72% - -  
Private clinic 2 0 0 - -  
House 27 3 11.11% - -  
Farm, garden and forest 0 0 - - -  




Single 32 2 6.25% - -  
No Intention 193 19 9.84% - -  
Unknown 53 3 5.66% - -  
Consultant for health problem 
Husband/wife 168 19 11.31% - -  
Other family members 227 22 9.69% - -  
Medical staff 726 69 9.50% - -  
Village health volunteer 30 2 6.67% - -  
Local authority  4 1 25.00% - -  
Friends / neighbors 30 3 10.00% - -  
Others 107 11 10.28% - -  
(-): not applicable 
Most people choose health facilities for their/ their wife next pregnant, in which 
the prominent choice go for hospital with 56.33%; health station was the second selection 
out of places (7.53%) and health center (3.97%). The prevalence of HBsAg (+) in group 
choosing hospital (51; 9.46%) and house (n=3, 11.11%).  
Population usually come to medical staff for asking consultant (n=726, 75.9%) 
with lofty HBsAg (+) (n=69,9.5%), though this figure for partner (n=168, 17.6%; 
HBsAg(+):n=19,11.31%) and other family members (n=227, 23.7%; HBsAg(+): n=22, 
9.69%) and friend (n=30, 3.14%; HBsAg(+): n=3, 10%) are also admired.  
Table 9: Percentage of HBsAg (+) according to the reasons for refusing health care 
services 
Variables 





N % N % 
Refusing health care  services due to the financial condition  
Yes 52 5 9.61% - -  
No 865 78 9.01% - -  




Refusing health care  services due to the hospital condition or skill health staff 
Yes 14 2 16.67% - -  
No 921 81 9.64% - -  
No health problem 21 4 23.5% - -  
 
 
Figure 6. Reasons for refusing health care services 
 
F: Financial, Q: Qualification 
Most of participant have no problem of access health services in light of financial 
condition (n=865, 90.48%) and quality condition (n=921, 96.3%). The number of 
participants who refused to use health services were quite small in both above groups. The 
prevalence of HBsAg (+) was highest in group without health problem (F:10.26%; 
Q:23.5%), though the prevalence of positive cases in the group with no refusing health 
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Table 10: Percentage of HbsAg (+) according to the common diseases are refused by 
financial (F) and qualification (Q) condition 
Variables 
≥ 18 years old (n= 956) 






N % N % 
Categories of health care services  refusing due to financial condition 
Maternal and childcare 3 0 0 - -  
Immunization 2 0 0 - -  
Malaria 2 0 0 - -  
Tuberculosis 0 0 - - -  
Hypertension 1 0 0 - -  
Diabetes 6 0 0 - -  
Cancer 9 2 22.2% - -  
Rehabilitation 3 0 0 - -  
Others 30 1 3.3% - -  
Categories of health care services  refusing due to its qualification 
Maternal and childcare 0 0 0 - -  
Immunization 1 0 0 - -  
Malaria 0 0 - - -  
Tuberculosis 0 0 - - -  
Hypertension 1 0 0 - -  
Diabetes 1 0 0 - -  
Cancer 3 1 33.3% - -  
Rehabilitation 0 0 - - -  




Apart from mentioned diseases, cancer was the most popular disease (0.93%; 
0.3%) with the highest HBsAg (+) F:22%; Q: 33% respectively. Other diseases were mostly 
minor positive HBsAg (+) cases. 
Table 11:Percentage of HbsAg (+) according to the information acquisition channel 
about immunization schedule and immunization day for children of participants in 
Central region, Vietnam 
Variables 
≥ 18 years old  
(n= 956) 






N % N % 
Information acquisition channel about immunization schedule 
Medical staff 600 58 9.67% - -  
Village health volunteer 445 36 8.1% - -  
Immunization card 112 11 9.82% - -  
Brothers/sisters or friends 15 2 13.3% - -  
Radio / TV 66 9 13.64% - -  
Poster 14 1 7.14% - -  
Village head man/Unit village head 107 11 10.28% - -  
Women’s union 103 10 9.7% - -  
Others 5 0 0 - -  
Unknown 174 13 7.47% - -  
Information acquisition channel about immunization day for your children 
Medical staff 448 40 8.93% - -  
Village health volunteer 286 20 6.99% - -  
Vaccination card 17 3 17.65% - -  
Brother/ sister/ friend 38 4 10.53% - -  
Radio/ TV 8 1 12.50% - -  
Poster 70 8 11.43% - -  




Woman’s union 106 13 12.26% - -  
Megaphone 5 1 20% - -  
Invitation from the district governor 159 12 7.55% - -  
Others 797 75 9.41% - -  
Information acquisition channel about immunization schedule and immunization 
day for children from medical staff (n=600, 62.8%; n=448, 46.9% respectively), village 
health volunteer (n=445,46.5%; n=286, 29,9% respectively), immunization card (n=112; 
12.65%, n=17; 1.78% respectively). 
The prevalence of HBsAg (+) was the most prominent in receiving this information 
from media (radio, internet, TV) (immunization schedule 13.64%) and immunization card 
(immunization day for children: 17.65%), followed by getting from friends/ family 
members (immunization schedule 13.3%; immunization day for children: 10.53%). 
Table 12: Percentage of HbsAg(+) according to the person who make vaccinated 
decision 
Variables 
≥ 18 years old  
(n= 956) 






N % N % 
Person make vaccinated decision 
Father 64 5 7.81% - -  
Mother 466 41 8.80% - -  
Both mother and father 274 29 10.58% - -  
Grandfather/ grandmother 1 0 0 - -  
Village head man 151 12 7.95% - -  





The number of mothers who take responsibility for making vaccinated decision were 
468 out of 924 participants (48.7%). The prevalence of HBsAg (+) in mother sector (n=41, 
8.8%); both mother and father (n=29, 10.58%) while grandparents’ sector do not have any 
case. Besides, the others sector (single) was significant attention among sector with the 
high prevalence of HBsAg (+) (n=75, 9.32%).  
4.2. ASSOCIATION BETWEEN SEVERAL FACTORS AND PREVALENCE OF 
HBSAG POSITIVE IN CENTRAL REGION, VIETNAM 
Table 13: Logistic regression analysis of several factors related to prevalence of 




OR 95% CI p-value 
Age  group    
≥ 18 years old* 1.0 - - 
<18 years old 0.228 0.145-0.359 p<0.001a 
Reason to choose delivery place    
Complicated case* 1.0 - - 
Convenience 0.756 0.277-2.065  
Effortless delivery 1.029 0.504-2.102  
Financial and external condition 0.855 0.233-3.135  
Individual selection 2.264 1.045-4.904 p<0.05a 
Mother and child safety 1.937 0.905-4.145  
Quality administrative & experts 0.562 0.280-1.129  
Unknown 0.545 0.188-1.582  
Any family member has Hepatitis B    
Yes* 1.0 - - 
No 3.861 2.079- 7.171 p<0.001a 
Unknown 0.518 0.30- 0.895 p<0.05a 




Yes* 1.0 - - 
No 1.238 0.492-3.115  
Unknown 4.739 1.808-12.422 p<0.05a 
Availability of immunization cards    
Yes* 1.0 - - 
No 2.988 1.300-6.867 p<0.05a 
(*): reference group;  (-): no applicable 
a: Logistic regression model  
 After adjusting for other factors, logistic regression model gives the following 
results: 
- The proportion of participants in age group under 18 years old having lower chance 
to get HBsAg (+) 0.228 times, compared to the age group  ≥ 18 years  old.  
- The proportion of participants having their own individual selection getting HBsAg 
(+) was higher than complicated case sector, at 2.264 times.  
- The proportion of participants did not have and did not know their family member 
status of Hepatitis B having chance to get HBsAg (+) was higher 3.861 times and 
lower 0.518 times respectively, compared to the group of participants known their 
family member status.  
- The proportion of participants did not know their vaccination history getting 
HBsAg (+) was higher than those who have vaccinated before, at 4.739 times.  
- The proportion of participants having no immunization card getting HBsAg (+) 
was higher than those who had immunization card, at 2.988 times. 











OR 95% CI p-value 
Attendance for delivery  
p>0.05 
Medical staff    
No* 1.0 - - 
Yes 0.489 0.330-0.725 p<0.001a 
Village health volunteer    
No* 1.0 - - 
Yes 0.000 0.000- . p>0.05 
Traditional Birth Attendant    
No* 1.0 - - 
Yes 2.015 1.321-3.076 p=0.001a 
Family member & Relatives    
No* 1.0 - - 
Yes 1.891 1.087-3.289 p<0.05a 
By mother herself    
No* 1.0 - - 
Yes 0.000 0.000- . p>0.05 
Others (unknown)    
No* 1.0 - - 
Yes 1.543 0.546-4.367 p>0.05 
(*): reference group;  (-): no applicable 
a: Logistic regression model 
Note: Only relevant variables with statistical significance (p <0.05) in the logistic 
regression analysis is presented in the table above. 
 After adjusting for other factors, logistic regression model gives the following 
results: 
- There was an association between the prevalence of HBsAg (+) to people who 
attend to participants’ delivery in their birth delivery/ their wife’s birth delivery: 
 + The group of participants who had attend of medical staff has lower chance of 




 + The group of participants who had attend of traditional birth attendant has higher 
chance of getting HBsAg(+) comparing to those did not have this attendant, at 2.015 times. 
 + The group of participants who had attend of family member & relatives has 









5.1. DEMOGRAPHIC CHARACTERISTICS OF RESEARCH PARTICIPANTS  IN 
THE CENTRAL REGION OF VIETNAM 
As of appropriate 2,075 samples were selected in 4 provinces including Khanh 
Hoa, Ninh Thuan, Quang Ngai and Binh Dinh, which were divided into 2 age groups: ≥ 18 
years old: n= 956, 46.1%) and <18 years old: n=1119, 53.9%).  
5.1.1. Age, gender and location 
The decline in the prevalence of HBsAg in younger age groups may be attributed 
to the immunization program. Peng Huang et al presented the same trend of prevalence of 
HBsAg(+) was low in children (0.7-0.77%), and gradually increasing in the adolescent 
(1.4-2.55%) and adult aged ≥ 20 years old (5.69-11.22%)[83].  Susan T et al also indicated 
the risk of age and the prevalence of HBsAg (+) dependent in childhood and adult period 
in her study about estimate global HBV disease burden and vaccination impact acute HBV, 
indicated the prevalence of HBsAg(+) acute infected occur in ~1% perinatal, 10% early 
childhood and 30% of late infections, while the spread out of chronic HBV occur in ~90% 
of persons infected in perinatally, 30% infected in early childhood, and 6% in effected  after 
5 years of age. Therefore, it can explain for the risk of getting higher prevalence of 
HBsAg(+) in 18 years old and above age-group[7]. 
The number of participants in survey were equal in 4 provinces and Ninh Thuan 
got the highest proportion of HBsAg (+) in group ≥ 18 years old :11.72%; group <18 years 
old: 1.85% . Son Do et al conducted in 509 participants above 20 years old about Hepatitis 
B&C among adults living in Binh Thuan province, Vietnam, showing the prevalence of 
HBsAg(+) among participants was 15.3% (95% CI, 12.2-18.5%) higher than our study 
results[84]. The amount of female percentage was higher than male in ≥ 18 age-group 
(73.53%, 26.43% respectively) and this figure was equal in <18 years old age-group 




accounts for ~5.4%, the number of positive cases was mostly in male as approximately one 
and a half as female at 11.46% and 8.25% respectively in group ≥ 18 years old; but this 
figure was reversely with male: 1.18% and female: 2.65% respectively in group <18 years 
old. Possible hypothesis can explain by the rapid test used in this study has a reported 
sensitivity of 95%; therefore, the HBsAg prevalence in this study might be lower than the 
true seroprevalence. Plus, the overlapped the time of interview to the harvest time, so most 
of mother will take their children to interview days. Besides, the random collection samples 
may get the proportion of female higher (1269 samples).  
5.1.2.  Levels of education 
The research involved some information spending only for participants over 18 
years old to identify their understand and behavior toward HBsAg(+), including 956 
samples. Most of participants ≥ 18 years old have low level of education. The highest 
HBsAg(+) percentage was the most prominent in medium education level (high school) 
(24;10.13%), high level education (college and above) (17; 9.39%), low level of education 
(none, primary school and junior high school) (46; 8.85%) and others was not significant. 
Balaeva T et al shared the different progressive trend as our result in their seroprevalence 
of markers of Hepatitis B virus infection in 1243 adults from 18-39 years old in 
Arkhangelsk, Northwest Russia that the prevalence of HBsAg(+) in the low level of 
education was the most higher (15.8%), though this figure between medium and high 
education level were pretty equal (9.9%, OR: 0.59, 95% CI: 0.35-0.999) and (10%, OR: 
0.59, 95% CI: 0.38-0.92)[85].  Peng Huang et al demonstrated the prevalence of HBsAg(+) 
in local residents of all age groups living in Jiangsu provinces, Eastern China that 
participants who were illiterate or had primary school diplomas had the highest HBsAg 
prevalence (9.82%, 95%CI: 9.60%-10.05%), followed by middle school (8.35%, 95%CI: 
8.09%-8.62%) and college school groups (8.05%, 95%CI: 7.42%-8.70%)[83]. 
5.1.3. Occupations  
The popular career in selected participants were farmer/fisherman (35.9%); 




prevalence of HBsAg (+) was the most prominent in labor/work for factory (7;11.67%), 
followed by the government and public officer (13; 10.57%), the others popular sectors 
such as farmer/fisherman, merchant, housework share quite similar proportion of HBsAg 
(+) in the range from 9.24-9.59%; lower cases in groups of company worker (1;5%) and 
freelancer (2,2.6%). Comparing to the ubiquitous levels of HBsAg (+) proportion in, 
mother and their children in Laos people, 2015 by Komada et al, farmer prevalence 
accounted for the highest figure at 64.64%, (with HBsAg (+) children 2.21%; 95% CI 1.02-
3.4 and mother: 3.23%, 95% CI 1.79-4.66), though the number of fishermen was the lowest 
one due to their geography as a landlock country. The prevalence of HBsAg (+) in all 
sectors in Laos is lower to Vietnam figures. The highest proportion of HBsAg(+) in Laos 
people belonged to merchant (children 5.56%; 95% CI 0.00-11.87 and mother:11.11% , 
95% CI 2.45-19.77), though this figure on labor sector was on second high 
position(3.39%)[86]. 
5.1.4.  Income 
In average, the annual income for each household are range from under 25 million 
VND to over 50 million VND and there was no big gap percentage difference among those 
groups (≥50.000.000 vnd: 24%; < 50.000.000 vnd & ≥25.000.000 vnd:19.87%; 
<25.000.000 vnd:  20.7%). The significant HbsAg (+) percentage ≥50.000.000 vnd group 
(24; 10.43%), followed by the groups have no respond, while the percentage of other 
groups are quite similar (<50.000.00 and ≥25.000.000 vnd 16; 8.42%; <25.000.000 vnd: 
16; 8.08%). Balaeva. T et al conducted in 1243 adults from 18-39 years old in Arkhangelsk, 
Northwest Russia, 2010-2011 showed the participants with low income has higher 
serological marker of HBV, with low, medium and high income are 15.5%, 10.1%, 9.9% 
respectively[85]. Jindai N et al determine the prevalence of sexual transmitted infections, 
including Hepatitis B among 500 pregnant women, which demonstrates the elevated of 
HBsAg (+) in group having low and upper socioeconomic status are equally (2.7%)[87]. 
Comparing to other studies, we present adverse results with the positive HBsAg are highest 




reason related to society issue (unsafety sexual behavior of husbands, history of STIs in 
their partners, or no re-vaccination for a long time, especially in adults). Besides the number 
of people do not prefer to answer was quite high (33.2%) with the significant HBsAg (+) 
percentage (31; 9.17%), even higher than the ≥50.000.000 vnd sector, it was very difficult 
to identify the relevance of affection of income and HBsAg (+) prevalence.  
5.2.  ENVIRONMENTAL FACTORS AFFECT TO USING HEALTH CARE 
SERVICES OF PARTICIPANTS IN CENTRAL REGION, VIETNAM 
5.2.1. Accessibility to health facility  
5.2.1.1. Main transportation to the nearest health facility  
Participants tend to use the motorbike (87.04%) as a priority transportation to 
approach the nnearesthealth facility, the second way was going on foot (7.2%).  The other 
vehicle (bicycle, car, electric bicycle) are not popular use. The prevalence of HBsAg(+) 
was highest in group using motorbike (≥ 18 years old (n=82; 9.62%) and <18 years old (n= 
20; 2.1%) and in on foot sector, this prevalence (≥ 18 years old: =5; 7.69 %) and <18 years 
old (n= 5; 5.88%), others groups has no positive cases. Komada et al studied on 911 mother 
and their children in Laos, 2015 showed the main transportation to the nearest health 
facility much more variety (bicycle, car, hand tractor, on foot,…) than our result, though 
motorbike was the most popular vehicle (554; 61.15%) and this belonged participants in 
this sector presented the highest number of HBsAg(+) cases in both mother (21, 3.79%, 
95% CI: 2.20-5.39) and their child (15; 2.71%, 95% CI: 1.35-4.06)[86]. 
5.2.1.2. Time to nearest health facility 
The distance between their house and health facility taking mostly under 15 
minutes accounts for the highest proportion (88.9%), though the highest proportion of 
HBsAg (+) in both age groups in the participants approach to health facilities over 30 
minutes (≥ 18 years old: 4; 10.53%) and <18 years old: 2; 6.6%). It is predicted by the 
difficult approach to the health facilities, which makes population could not have early 




was the most prominent in range from > 10minutes to ≤30 minutes by Komada et al, 
though the prevalence of HBsAg(+) were highest in ≤10 minutes sector in both mother 
(10; 5.75%, 95% CI: 2.25-9.24) and their child (8, 4.6%, 95% CI: 1.45-7.74)[86].  
5.2.2. Health services 
5.2.2.1. Place of giving birth 
 Using health facilities for delivery was the top noteworthy considered option  
(hospital: 50.3%, health station: 13%, health center: 9.6%), while the percentage of  having 
birth at home still existed (22.9%).  The prevalence of HBsAg (+) was highest in delivery 
in house (≥ 18 years old: n=37, 10.54 % and <18 years old: n= 7; 5.6%), followed by health 
station (≥ 18 years old: n= 16, 8.84 % and <18 years old n=5; 5.62%),  and hospital (≥ 18 
years old: n=26, 8.75 %) and <18 years old: n=11; 1.46%). At home, participants do not 
have adequate and hygiene medical equipment, hence, the risk of getting HBsAg (+) was 
very transparent high. We share the homogeneous trend of Hien Nguyen et al on 6.949 
children in Vietnam in the period from 2000-2008 to identify the effectiveness of 
vaccination that the prevalence of HBsAg(+) was dramatically higher (5.47%) than whom 
were born in health facilities (2.25%) (PR: 2.43, CI:1.68–3.51)[72]. Geographical factor 
appearance was considered as an issue for proportion of HBV infection and Hep BD 
coverage. In Cambodia, Indonesia, and China, there was a linked between low HepB-BD 
coverage and home births delivery[88-90]. Following Bunsoth Mao et al’s study about the 
prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B 
vaccination program among in 1196 children in three provinces in Cambodia, 2011 
demonstrated the number of infants who were born in health facilities with SBA, children 
born at home without a SBA were more likely not to have received a timely BD (aRR=1.94; 
95% CI=1.75–2.15). Additionally, the risk of not receiving a timely BD was also greater 
among children born at home with an SBA when compared with children born in a health 
facility with an SBA (aRR = 1.54; 95% CI = 1.32–1.80).  The reality explanation for this 
reason because of far distance (remote province) between home and health center, 




delivered without an SBA at home requires the mother to visit a health facility within 24 
hours of delivery which can be challenging[88]. Sharing the same difficulty, Indonesia 
experienced HepB-BD challenge in their country, which the majority of delivery was at 
home, approximately 94% and most of those were attended by TBAs (in Lombok). There 
was only less than 5% deliveries were attended by a midwife or nurse, who gave the HepB-
BD. Even though they had trained injection-givers were attended to the deliveries, who can 
give a HepB-BD immediately, the results still remained a substantial missed opportunity 
to provide timely immunization, 39% infants were immunized on the 7th date[89]. 
 It showed a higher prevalence of chronic HBV infection among children 
delivered at home than those born at large hospitals in China and Vietnam, which 
emphasized the importance of timely delivery of HepB-BD[72, 91].  Fuqiang Cui and Lili 
et al made a cohort study aiming to evaluate factors associated with effectiveness of the 
first dose of hepatitis B vaccine in China from 1992 to 2005 and demonstrated the positive 
correlation between HBs-Ag positive status and place of birth (at home: OR=2,52; 95% 
CI=186-3,43 ;p < 0,001 and township: OR=1,54; 95% CI=1,17-2,03; p = 0,002)[91]. 
In 2015, study of Kenichi Komada et al about chronic hepatitis B through 
seroprevalence as determined from dried blood spots, among 911 pairs of children and their 
mothers in central Lao People’s Democratic Republic showed the prevalence of hepatitis 
B vaccine in immunization program was 87%. The number of children whose mother’s 
HBsAg positive was 11 out of 21 children, reached at 52,3%. The maternal HBsAg 
positivity and being born in a non health facility in children shared the similar positively 
associated with hepatitis B infection[86]. 
5.2.2.2. Attendant for delivery  
Most of attendant for delivery for both age-groups were health staff such as 
medical staff (75.2%); traditional birth attendant (17.8%) and family members & relatives 
(8.4%). However, the prevalence of HBsAg (+) in family members & relatives sector (≥ 
18 years old:13; 12.62% and <18 years old: 3; 4.17%) was the highest, then mother herself 




26; 9.25%) and <18 years old 7; 7.87%), medical staff attendant (≥ 18 years old : 52; 9.09%) 
and <18 years old: 16; 1.62%). We expect that medical workers will have more experience 
and knowledge to reduce the transmitting of HBV during delivery from mother to their 
children than family members or relative.  Moreover, a study of assess the ability of control 
HBV infection in Eastern Mediterranean by WHO of Robert D et al indicated 62% of all 
birth in EMR was born in health institutions with 67% medical staff’s support in 2014. 
However, countries without universal HBV birth dose, only 49% of babies’ delivery in 
health institution with 54% medical staff attendant, compared with 86% and 92% 
respectively in nations have universal HBV birth dose[92].Plus, the chance of newborn 
receiving hepatitis B vaccine within 24 hours after delivery was higher if they were delivery 
in health facilities with medical staff[93]. 
5.2.2.3. Reason for choosing this delivery place 
The convenience (≥ 18 years old: 218; 22.8%) and <18 years old: 185; 16.5%)  and 
mother and child safety  (≥ 18 years old: 253; 26.5% and <18 years old: 555; 49.6%) are 
privilege reason for choosing delivery places. The prevalence of HBsAg (+) was highest in 
complicated case (in ≥ 18 years old group (4;19.05%) though this figure in < 18 years old 
group was financial and external condition (4;9.52%). Oppositely,  Prahlad Rai Sodani et 
al. measured 561 patient satisfaction in reasons for choosing health facilities (76-86%, 
depending on DH, CHC, PHC, etc,….) mostly focus on quality of infrastructure more than 
skilled medical staff[94]. 
5.2.3. Hepatitis B infection risks  
5.2.3.1. Blood transfusion 
Blood transfusion did not exist in many ≥ 18 years old participants (880; 92.5%), 
though the prevalence of HBsAg (+) in group having blood transfusion was higher 2.26 
times comparing to group having no blood transfusion (20%; 8.86% respectively). The study 




Nguyen et al shares the resemblance trend with our result, indicated the prevalence of 
HBsAg(+) people having blood transfusion was 88.9%(  OR: 3.55, 95% CI: 1.06-11.90)[8]. 
5.2.3.2. Tattoo 
E.R. Miller et al showed the prevalence of HBsAg(+) in participants having tattoo 
(36.9%) higher than people never had (30.7%)(RR: 1.2, 95%CI : 0.89-1.62 ) in a network 
of injecting drug users in Melbourne, Australia[95]. Reversely, our results shared the 
different trend as ≥ 18 years old participants group having no tattoo with (897; 93.8%) but 
its prevalence of HBsAg (+) was higher comparing to group having tattoo (9.25%, 6.78% 
respectively). We basically concluded that the prevalence of HBV infection in Vietnam was 
high even people do not get any risk from transmitted factors above, the probability of 
expose to HBV could be possible. 
5.2.3.3. Frequency of surgical operation 
The proportion of population never have had surgical operation (n=682; 71.6%). 
The prevalence of HBsAg (+) was higher progressively as the increasing of the number of 
surgical operation times (never: n= 62; 9.09%; once: n=15; 9.15%; twice or more: n= 9; 
10.59%). Similarly, Maria Gancza et al’s study about serosurvey on hepatitis B vaccination 
uptake among adults patients from GP practice in a region of South – West Poland in 2013 
showed the higher immunization rate in patients who had surgery before (64,4%) than those 
not having surgery(35,5%) (OR=2,73; 95% CI= 1,697- 4,433;  p< 0,0001). The majority 
reasons of this figure because of HBV immunization (57,7%) and recommendations by GPs 
(4,8%)[96]. 
5.2.3.4. Family member have Hepatitis B 
Mostly, people have no family members having Hepatitis B (642/956). The 
prevalence of HBsAg(+) was the higher in participants group having Hepatitis B (28; 
30.43%), as 5.4 times compared with the group have no Hepatitis B (36; 5.61%),  However, 
the positive status of HBV infection in group do not know their family status was 
significantly (23; 10.36%). Study of Son Huy Do et al conducted in 509 adults participants 




seropositivity was related to family history of liver disease in both the univariate analysis 
(OR = 3,1; 95% CI= 1,9–5,3; P < 0.0001) and the multivariate analysis (adjusted OR = 3.0; 
95% CI, 1.7–5.2; P < 0.0001) respectively[84]. 
5.2.4. Vaccination 
5.2.4.1. Vaccination history 
There are prominent number of having vaccination in both age-groups (≥ 18 years 
old (n= 634; 66.33%); <18 years old (n= 1066; 95.21%). The prevalence of HBsAg(+) in 
group  ≥18 years old (n= 82; 8.58%) was higher than group <18 years old(n= 25; 2.19%); 
and the prevalence of HBsAg(+) in participants have no historical vaccination in group  ≥18 
years old(n= 32; 15.09%) was higher than group <18 years old( 2; 10%); and this prevalence 
was higher as well above twice comparing to group having historical of vaccination (≥ 18 
years old: n=5 0; 7.89%;  <18 years old: n= 23; 2.16%).  
5.2.4.2. Vaccination site 
Health station was the most popular place for vaccination out of options (73.1%), 
followed by  hospital (8.5%) for both age groups. Because, EPI normally conducts in health 
stations and health centers to create opportunity for every children can reach immunization.  
Hence, the prevalence of HBsAg (+) in health center was the highest (≥ 18 years old:n= 6; 
12%); <18 years old: n= 1; 2.17%); but the second position is in health station (≥ 18 years 
old: n= 44; 7.97%; <18 years old: n= 21; 2.14%); hospital has the proportion of positive 
cases (≥ 18 years old: 2; 6.25%; <18 years old: n= 1; 0.69%).  
5.2.4.3. Availability of immunization cards 
Notably, the absence of their immunization card (86.7%) was high in both age-
groups, which the prevalence of HBsAg (+) in this group was (≥ 18 years old: n= 87; 
9.15%; 9 times higher compare to group having immunization card; <18 years old: n= 19; 
2.28%; quite equal to group having immunization card (n= 6;2.11%)). 
In general, Vietnam had been being one of the top countries having high HBV 
infection prevalence worldwide. Regarding ≥ 18 years old group, the prevalence of HBsAg 




historical immunization group, while it maintains quite equal prevalence in <18 years old 
group. Possible hypothesis can explain for figure because this age group was born in the 
period of beginning the EPI and trial period since 1980, hence the proportion of children 
have adequate vaccination at that time was lower than this figure in current. Plus, a huge 
number of absence immunization cards prove for awareness of keep tracking of vaccination 
doses. According to Yen-Hsuan Ni et al investigated on 1916 persons from 0 to 20 years 
old before the mass vaccination program in Taipei, Taiwan, 1999 that missing vaccination 
card was popular in the older age group and vaccination coverage rate was higher in 
children under 15 years old than who are over 15 years old (p<0.001)[97]. 
5.2.5. Immunization in 12-48 months old in Central region, Vietnam 
The number of children not having Hepatitis B birth dose was very high, which 
indicated the highest prevalence of HBsAg (+) in this group comparing to other groups. 
Proper time immunization doses tended to increase, especially in Hep 2 (n=132, 50%) and 
Hep 3 (n=109, 41.28%). However, the number of those having no immunization is still 
high dramatically, range from 37-57%. The prevalence of HBsAg (+) was increasing 
gradually in improper time immunization group (0%-3.77%) and remained quite steady in 
both groups: proper time immunization (0.92%-1.52%) and no immunization (0.98%- 
1.99%), respectively.  
The number of infants having vaccination was low, at n=96, 36.3%. The 
prevalence of HBsAg(+) of children having birth dose accounted for 1.04%, which was 
lower than those did not have birth dose, at 1.99%. Among 4 Hepatitis B doses, Hep1 got 
lowest proportion in 2 sectors: proper time immunization (26.5%); no immunization 
(37.1%) but highest in improper time immunization sector (36.7%). Hep 2 and Hep 3 
shared the resemblance trend of growing proper time immunization doses, though group of 
having no vaccination group with high proportion. Conversely, Dao et al studied among 
children in the period from 2000-2011 indicated the children under 5 years old have low 




2000 and 2011, though this figure increased in the first dose of HBV at the same period. 
Particularly, whose mother did not get at least primary school[98]. 
There had no case positive with HBsAg (+) with proper time immunization and 
adequate vaccination (3.13%) and 3 cases (1%) had positive with HBsAg (+) with improper 
time immunization and (or) inadequate vaccination. Possible hypothesis might be 
explained due to priority of parents mainly worked on agriculture sectors or blue-collar and 
housework without time arrangement, so they cannot take their children to vaccinate on 
time. Besides, we can evaluate the role of proper and adequate vaccination (including HBV 
birth dose and 3 doses polyvalent vaccines in an early stage of life), protecting children 
against to HBV infection as well as declining the prevalence of HBsAg (+) in community. 
It primarily can explained that the subjects were too young to have HBsAg(+) and we need 
to follow up until their adulthood to detect in a longitudinal research.  
5.3. ATTITUDE FACTORS AFFECTS TO USING HEALTH CARE SERVICES 
OF PARTICIPANTS IN CENTRAL REGION, VIETNAM 
5.3.1. Intended delivery place for next pregnancy and consultant for health problem  
5.3.1.1. Intended delivery place for next pregnancy 
Most people chose health facilities for their/ their wife next pregnant, in which the 
prominent choice go for hospital with 56.33%; health station was the second selection out 
of places (7.53%) and health center (3.97%). The prevalence of HBsAg (+) in group 
choosing hospital (51; 9.46%) and house (3; 11.11%). Recently, people aware of the 
importance of delivery in health facilities to secure their birth labor and reduce the risk of 
getting infection. Besides, the number of participants still asked for deliver in their house 
was existing. According to Vanphanom et al invested in rural Laotians for choosing home 
deliveries over health facilities because of finance burden, distance between health 
facilities and their house as well as the attitude of health staff and wishing of traditional 






5.3.1.2. Consultant for health problem 
Population usually came to medical staff for asking consultant (n=726;75.9%) with 
lofty HBsAg (+) (n=69; 9.5%), though this figure for partner (n=168; 17.6%; HBsAg 
(+):n=19;  11.31%) and other family members (n= 227; 23.7%; HBsAg(+): n=22; 9.69%) 
and friend (n=30; 3.14%; HBsAg(+): n=3; 10%) were also admired. Possible hypothesis 
for this issue that mostly Vietnamese do not have routine of medical check-up annually. 
Similarly, to other disease, hepatitis B patients come to see health workers when their 
symptoms appears, and the prevalence of HBsAg (+) of this sector was quite high. 
However, family members normally played an important role in giving consultant 
following our custom.  
5.3.2. Reason for refusing health care services and common diseases are refused by 
financial and qualification condition. 
Most of participant had no problem of access health services in light of financial 
condition (n= 865; 90.48%) and quality condition (n= 921; 96.3%), the number of 
participants refuse to use health services are quite low in both above groups. The prevalence 
of HBsAg (+) was highest in group have no health problem (F:10.25%; Q:19%) because 
they supposed to be healthy until the symptoms appears. 
Apart from mentioned diseases, cancer was the most popular disease (0.93%; 
0.3%) with the highest HBsAg (+) F:22%; Q: 33% respectively. Other diseases were mostly 
minor positive HBsAg(+). The quality of cancer treatment in Vietnam does not get the high 
belief from patient, especially in provincial levels and lower. Besides, cancer costs amount 
of patient’s expenditure, especially for low income people. They usually use traditional 
remedy instead of medical treatment.   
5.3.3. Information acquisition channel about immunization schedule and 
immunization day for children of participants in Central region, Vietnam 
Information acquisition channel about immunization schedule and immunization 
day for children from medical staff (n=600, 62.8%; n=448, 46.9% respectively), village 




12.65%, n=17; 1.78% respectively). In Vietnam, medical staff will send the invitation 
letter for parents to take their children for vaccination. 
The prevalence of HBsAg (+) was the most prominent in receiving this 
information from media (radio, internet, TV) (immunization schedule 13.64%) and 
immunization card (immunization day for children: 17.65%), followed by getting from 
friends/ family members (immunization schedule 13.3%; immunization day for children: 
10.53%). 
5.3.4. Person make vaccinated decision 
Mothers who take responsibility for making vaccinated decision was 468 out of 
924 participants (48.7%). The prevalence of HBsAg (+) in mother sector (n=41, 8.8%); 
both mother and father (n=29, 10.58%) while grand-parents sector did not have any case. 
Besides, the others sector (single) was significant attention among sector with the high 
prevalence of HBsAg (+) (n= 75; 9.41%) 
5.4. ASSOCIATION BETWEEN SEVERAL FACTORS AND PREVALENCE 
OF HBSAG POSITIVE IN CENTRAL REGION, VIETNAM  
5.4.1. Age 
 The proportion of participants in age group under 18 years old having lower chance 
to get HBsAg (+) 0.228 times, compared to the age group  ≥ 18 years  old. In a national 
survey about sero-prevalence of hepatitis B infection in 965 participants from 2-90 years 
old in Nigeria of Adebola T. Olayinka et al, the percentage of people who were at risk of 
HBV infection declined momentously with the increasing age (2 for linear trend = 29,2 ; 
P < 0.0001)[100]. However, Tatiana Balaeva et al conducted study on seroprevalence of 
markers of HBV infection, a population- based in 1243 young adults in Arkhangelsk, 
Northwest Russia, which had two times higher of the prevalence of serological of HBV 
among participants aged 30–39 years compared to those aged 18–29 years[85]. It also 
showed the same tendency for anti-HBc for those age-groups, at 22,8 and 10,6 respectively 
in 6,217 volunteers in Moscow region who were observed after 10 year conducting  mass 




hepatitis B and C in a municipality with rural characteristics: Cássia dos Coqueiros, State 
of Saõ Paulo, Brazil in 2015, which divided 1001 participants into six age-groups from 18 
to over 64 years old. It depicted a progressive increase in positivity with HBV by age (p = 
0,009) which the most prominent age-group was 55-64 years old (8,4%)[102]. Study of 
Son Huy Do et al conducted in 509 adults participants from 20-81 years old in  Binh Thuan 
province, Vietnam, 2012 presented the HBsAg positive prevalence was lower following 
the decrease with age, which was related to age of 50 years or over (OR = 0.3; 95% CI, 
0.1–0.6; P < 0.001), while HBV exposure was associated with age of 40–49 years (OR, 
1.8; 95% CI = 1.0–3.0; P < 0.05) and age of 50 years or over (OR= 1.8; 95% CI = 1.1–3.1; 
P < 0.05) in univariate analysis. Multivariate analysis identified that HBsAg seropositivity 
was related to age of 50 years or over (adjusted OR = 0.3; 95% CI= 0.1– 0.6, P < 0.001), 
whereas HBV exposure was still associated with age of 40–49 years (adjusted OR = 1.8; 
95% CI, 1.0–3.1; P < 0.05) and age of 50 years or over (adjusted OR = 1.8; 95% CI, 1.1–
3.1; P < 0.05)[84]. Our study partly presented the efficiency of vaccination, when most of 
participants over 18 years old did not have chance to immunization adequately in their 
childhood, resulted in the prevalence of HBsAg (+) higher in this groups, comparing to the 
group under 18 years old.  
5.4.2.  Attendance for delivery 
There was an association between the prevalence of getting HBsAg (+) to 
participants whose delivery had attend of medical staff (OR:0.489, 95% CI: 0.330-0.725, 
p<0.001); traditional birth attendant (OR:2.015, 95% CI: 1.321-3.076, p=0.001); family 
member & relatives (OR:1.891, 95% CI:1.087-3.289, p<0.05) comparing to those who did 
not have these attendants. In our study, we found the important role of medical staff who 
has experiences and skills in support delivery, lead to the prevalence of HBsAg (+) in this 
group was lower. However, the birth delivery having attend of traditional birth attendant 
and family member and relatives, which enhanced the prevalence of HBsAg (+) in 
community. Possible hypotheses explain that those people do not have enough skills as 




Allison et al in his study about “Hepatitis B vaccine birth dose coverage correlates 
worldwide with rates of institutional deliveries and skilled attendance at birth”, collected 
individual country data on the latest IDR and SBA rates reported by each country in 2017, 
it indicated significant positive correlations between HepB-BD coverage and IDR (rho = 
0.42, p < 0.001), SBA rate (rho = 0.44, p < 0.001), the density of hospital (rho = 0.33, p = 
0.02) and total health expenditure per capita (rho = 0.24, p = 0.03) in worldwide. 
Additionally, IDR also has a high correlation with SBA (rho = 0.94, p < 0.001) and adults 
literacy rates (rho = 0.52, p < 0.001) respectively[103]. Hang Pham et al implemented a 
study to evaluate knowledge, attitude and practice of hepatitis B prevention and 
immunization in 380  pregnant women in the range of 17 to 45 years old who lived in two 
northern provinces Vietnam. Regarding to place taking delivery, giving birth at province 
level hospital was independently associated with maternal antenatal HBV screening uptake 
(OR= 6,61; 95% CI = 2.04–21.45) and  the proportion of HB immunization in infant (OR= 
4.39; 95% CI= 1.48–13.02)[104].  
5.4.3.  Reason to choose delivery place 
 Participants tended to choose health facilities due to their delivery risks, such as 
heart disease, infectious factors, and concerned about the successful of birth delivery. The 
proportion of participant having their own individual selection getting HBsAg (+) was 
higher than complicated case sector, at 2.264 times. Possible hypothesis can explain within 
the complicated cases, participants chose health facilities for reducing the risk of their 
delivery and also decline the possibility of HBV transmit. Then with group of individual 
selection, it might had more risk of increase the high contagious factors if their choose 
delivery place like home, or others place different from health facilities.  
5.4.4. Family member status of Hepatitis B 
 The proportion of participants did not have and did not know their family member 
status of Hepatitis B having chance to get HBsAg (+) was higher 3.861 times and lower 
0.518 times respectively, compared to the group of participants known their family member 




impact of vaccination collected randomly and investigated 148.931 individuals by 
multistage random sampling in Eastern China. There was a relation between the higher 
proportion of HBsAg positivity and the lower of participants whose without familial history 
of HBV (p<0.005). Furthermore,  12.016 out of 148.931 participants had familial history 
related to HBV infection (8.28%, 95%CI: 8.14%-8.43%), which analyzed separately into 
different classes showed a statistically significant increase for mothers, fathers, spouses, 
offspring and siblings to HBV infection risks[83]. Ala U Tokan’s study also presented the 
relevant between HBsAg(+) and the number of HBV carrier in family that among single 
HBV carrier got 57 percent while this figure among families having three or more 
HBsAg(+) members was 98%, irrespective of family size (p < 0.05). It also indicated a 
trend toward a greater HBV proportion in children whose mothers had HBsAg-positive 
than those had HBsAg-negative[105].  
5.4.5. Vaccination history 
Our study showed the proportion of participants did not know their vaccination 
history getting HBsAg (+) was higher than those who have vaccinated before, at 4.739 
times. Hsien-ChengChang indicated in her study about seroprevalence of Hepatitis B viral 
markers among 7592 freshmen from one university in Northern Taiwan participated in 
entry health exam in September 2003 and September 2004 to evaluate 20 years after mass 
Hepatitis B Vaccination Program in Taiwan. The seronegative rate was 21.5% in subjects 
with self-reported hepatitis B vaccination history, and 38.9% in those without self-reported 
hepatitis B vaccination history. In addition, the seronegative rate of subjects born before 
July 1984 and after July 1984 was 19.2% and 21.8% in subjects with self-reported hepatitis 
B vaccination history, and 33.5% and 41.5% in those without self-reported hepatitis B 
vaccination history, respectively (p < 0.001) [106]. 
 
5.4.6. Availability of immunization cards 
 The proportion of participants having no immunization card getting HBsAg (+) 




immunization card, participants can keep track of the vaccination schedule and vaccinate 
adequately, hence it helps to reduce the prevalence of getting HBV infection. In study of 
Dambadarjaa Davaalkham about Serology results was conducted in 1,145 children (592 
boys and 553 girls) aged 7-12 years (survey response rate: 93%) that the proportion of 
subjects having HB vaccine among those having immunization cards accounted for 60.1%, 
and approximately of 65% children had received the birth doses on time whereas the 
remaining subjects received the birth dose late (31.9%) or birth doses of HB were not 
administered (3.4%)[107]. 
5.5. LIMITATION 
Our study was just included the specific Central Region, which may not represent 
the whole country. Since children from 12-24 months old provided low immunization card 
availability, it is difficult to draw any conclusion about the severity of HBsAg (+) among 
children in the community. Further studies involving which some essential issues (income, 
tattoo), lead to participants denied answering.  
5.6. FURTHER RESEARCH 
Regarding the overall prevalence estimates of particular participants in Central 
Region of Vietnam, the problem of sampling bias should not be underrated. The prevalence 
of HBsAg(+) in adult was considerable high; however, with the development and stable of 
EPI which help to reduce the proportion in children in the future. Continued surveillance 
is needed to monitor changing in Hepatitis B epidemiology before and after vaccine 
introduction. In addition to monitoring infection, changing the attitude and behavior of 
population plays important roles to assess whether vaccines are affecting the HBV infection 








Our study suggested that Hepatitis B infection was still a significant cause of 
among children younger and adult from 1-39 years old in Vietnam.  
In the context of low vaccine proportion or uncertain their historical vaccination, 
and the HBsAg (+) prevalence is mostly in the adults; getting a full schedule of  Hepatitis 
B vaccine and checking the status are very important, in particular, population who have 
not had chance to approach vaccination due to their external condition during their 
childhood and their behavior comparing to children.   
We also observed with the univariable regression logistic model and Chi-square, 
there are relevant factors with the prevalence of HBV infection in the population, including:  
- Age group: <18 years old (OR: 0.228, 95% CI: 0.145-0.359, p<0.001) 
- Attendant for delivery: Medical staff (OR: 0.489, 95% CI: 0.330-0.725, p<0.001); 
Traditional Birth Attendant (OR: 2.015, 95% CI: 1.321-3.076, p=0.001); Family 
member & Relatives (OR: 1.891, 95% CI: 1.087-3.289, p<0.05) 
- Reason to choose delivery place : Individual selection (OR: 2.264, 95% CI: 1.045-
4.904, p<0.05) 
- Family member have Hepatitis B: No (OR: 3.861, 95%CI: 2.079- 7.171, p<0.001;);  
Unknown(OR: 0.518, 95% CI: 0.30- 0.895, p<0.05) 
- Vaccination history: Unknown (OR: 4.739, 95% CI: 1.808-12.422, p<0.05) 
- Availability of immunization cards: No (OR: 2.988, 95%CI: 1.300-6.867, 
p<0.05;);   
There is a need to consider the community communication to vaccinate frequently 
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